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SUMMARY 
 
Engineered proteins have proven to be a very powerful tool both for basic research 
and industry. The next step in this direction is engineering biological pathways, such as 
signal transduction, which can set the foundations for a broad range of applications 
ranging from gene therapy to introducing novel properties in organisms. However a lot of 
biological processes are subjected to a lot of noise, which for most applications is not 
desired. For example, within a population of cells, different cells can express a gene at 
different levels ranging from zero to high expression. Therefore it is very important to 
design pathways whose output can be tightly controlled. Such a challenge is not easy to 
tackle, so before trying to addressing it in complex organisms, it is better to start from 
“simple” well-studied ones, like signal transduction in E.coli. 
Signal transduction in E.coli takes place mainly through two-component systems, 
consisting of a sensor-kinase and a response-regulator, which usually is a transcription 
factor, with few exceptions like CheY from the chemotaxis signalling pathway. In this 
study two of the best characterised signalling systems of E.coli are combined through a 
chimeric sensor, in order to construct a novel pathway: the ligand-binding domain of the 
aspartate receptor, Tar, from the chemotaxis pathway is combined with the catalytic 
domain of the osmosensor EnvZ resulting in the chimeric receptor Taz. Taz can activate 
gene expression from the porin promoters through phosphorylation of the response 
regulator OmpR, upon binding of a proper ligand, like aspartate. 
The aim of the study was to use this system as a template in order to construct a 
pathway whose output would be controlled by a gene circuit and to change the input 
signal through rational design. As an output a destabilised GFP was chosen and different 
circuitry were designed: competition of OmpR-P with TetR repressor, expressed from a 
synthetic promoter, for activation of the pompC promoter, expression of anti-sense RNA 
for the reporter gene (GFP) and finally a gene toggle switch, established by TetR and a 
temperature sensitive CI, which would be activated by OmpR-P and provide the tightest 
regulation of the output. Despite the different approaches used it was impossible to obtain 
stable constructs with sufficient promoter strength to have any effect compared to the 
simple reporter pompC-GFP.  
Rational design using Perla and Fold-X algorithms and SwissPdBViewer program was 
implemented on the crystal structure of the periplasmic domain of Tar in complex with 
aspartate. Although the power of this approach seemed very promising, when it was 
tested to predict the effect of mutations in the wild-type chemotaxis system, it was not 
successful in the case of changing the chimera’s ligand. This can be attributed to the fact 
that in the chimera the periplasmic moiety has a different conformation to the one in the 
wild-type receptor, caused by the fusion to the cytoplasmic domain of EnvZ. The latter is 
supported by experimental results showing that Tar and Taz do not have exactly the same 
sensing properties i.e. some signals of the same type for Tar can elicit opposite responses 
through Taz. 
However during the study it was necessary to re-examine in more detail the properties 
of Taz, leading for the first time to the discovery of ligands (amino acids) which can 
inhibit the receptor. This inhibition is proven to be stereo-specific and extremely tight, 
dominating even the effect of activators like aspartate. Furthermore, the intrinsic 
properties of the Taz-OmpR system found in this study gave a different perspective for 
the wild-type systems: activation of the EnvZ-OmpR system in E.coli during cell growth 
seems to take place through EnvZ and the catalytic domain of EnvZ is not sufficient to 
account fully for it. The most important finding was for the chemotaxis system where 
some of the inhibitory amino acids for Taz gave a novel complex response and revealed 
the existence of a yet uncharacterised adaptation pathway.  
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Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 1
Signal transduction in bacteria takes place mainly through two-component systems. 
The classical paradigm of such a system consists of a sensor protein and an effector 
protein called response regulator (Mizuno, 1998). The sensor is a kinase, usually a dimer, 
which utilises ATP to undergo  upon sensing the proper signal trans auto-
phopshorylation on a histidine residue which resides in a highly conserved domain, 
named Hpt (Histidine phospho-transfer domain, Aravind and Ponting, 1999) or H box 
(Parkinson and Kofoid, 1992). The phosphate group is subsequently transferred to an 
aspartate of the response regulator (RR) which causes a conformational change and/or a 
change in the oligomerisation state of the response regulator leading to a change in its 
activity. The RR is usually able to dephosphorylate itself, but the presence of the sensor 
(or sometimes of another protein) increase the dephosphorylation rate. It is worth 
noticing that the metal ion required for the phospho-transfer reaction resides in the RR. 
Therefore the RR seems to be the sensor’s phosphatase and the phosphorylated RR is an 
enzyme intermediate with intrinsic long life-time, compared to other enzyme 
intermediates (Perraud et al, 1999). From this point of view the enhancement of 
dephosphorylation by the sensor can be due to an allosteric effect or by contribution of 
some residues in the formation of an active site with better catalytic properties. The latter 
is supported in cases like the EnvZ-OmpR system, where the reverse reaction (phospho-
transfer from phosphorylated OmpR to EnvZ) has been observed (Duta and Inouye, 
1996). 
The significance of these systems has rendered them a topic of detailed study, 
generating a lot of qualitative and quantitative information which can be used as basis for 
engineering new signalling pathways. However, there are still a lot of unknown 
parameters, even in the best described systems. Combining parts of different pathways 
can in some cases help  to reveal unknown parameters or players, or create novel 
properties that can be used to engineer new pathways. 
In this study components from the chemotaxis signalling pathway and the EnvZ-
OmpR system from E.coli are combined in order to by-pass some inherent problems of 
each system. The new system retains some of the properties of the original systems, but 
also has novel properties, some of which high-light properties, originating from the 
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parental systems, which were not described up to now. Before looking into the system 
used, it is important to look into the two parental systems and their intrinsic properties. 
 
The EnvZ-OmpR two component system 
 
Although the EnvZ-OmpR system is found only in enterobacteria, its structure is that 
of the typical two-component system, having extended homology of EnvZ to other 
histidine kinases and OmpR to response regulators, rendering it a model two- component 
system. In fact OmpR establishes a family of structurally homologous transcription 
factors (Itou and Tanaka, 2001). 
The main stimulus of the EnvZ-OmpR system in E.coli is the osmolarity of the 
environment. This system controls the expression of the porins OmpF and OmpC (Lan, 
and Igo, 1998). Like all two-component sensors, EnvZ has the ability of trans-
autophoshorylation and transfer of the phosphate group to OmpR, yielding OmpR-P, 
which is the active form of OmpR. Moreover it plays a crucial role in the 
dephosphorylation of OmpR-P. A schematic drawing of EnvZ depicting the characteristic 
domains of Histidine kinases and a model for the trans-phosporylation, based on the 
available crystal structures, is shown in fig.I-1. 
 
 
Fig I-1. (A) Schematic drawing of the EnvZ monomer depicting the conserved regions in histidine 
kinases and the available crystal structures for the dimerization and catalytic domain.(adapted from Hsing 
et al, 1998 and Tomomori et al, 1999) (B) Model of the transphosphorylation based on the available crystal 
structures. The pink sphere represents ATP (adapted from Cai et al 2003) 
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Thus EnvZ’s conformational state will determine the balance of the two opposing 
reactions, leading to a certain concentration of OmpR-P. Under low osmotic pressure, 
this concentration  is sufficient to activate transcription mainly of the porin which forms a 
pore with bigger diameter, OmpF. As the osmolarity increases, the concentration of 
OmpR-P increases as well, leading to activation of transcription of OmpC (fig.I-2). This 
occurs through co-operative binding of OmpR-P to three sites upstream the promoter 
(pompC) termed C1, C2 and C3 (Mizuno and Mizushima, 1986). Simultaneously, OmpF 
is down-regulated by the anti-sense RNA micF and by binding of OmpR-P to an 
inhibitory low-affinity site, so that the sum of the two different porins remains constant 
(Mizuno, 1998). This is true only until the mid-logarithmic phase of cell growth, after 
which there seems to be an activation of transcription of both porins through an unknown 
mechanism (Martinez-Flores et al, 1995). 
Despite the fact that we know a lot on the system, the actual way that EnvZ senses 
osmolarity remains elusive, rendering EnvZ inappropriate for engineering, i.e. since the 
exact signal is unknown it is impossible to try to change the specificity of the receptor 
towards a chosen small molecule, through rational design. 
 
 
 
Fig. I-2. The EnvZ-OmpR system. Increase in the medium osmorality increases the level of OmpR-P to 
levels that activate transcription of the porin OmpC and repress transcription of OmpF. The anti-sense 
RNA for OmpF, micF, ensures a tight regulation of OmpF expression. Adapted from (Mizuno, 1998) 
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The chemotaxis signal transduction pathway in E.coli. 
 
E.coli have the ability to sense and swim towards higher concentrations of nutrients 
(attractants) and away from higher concentrations of noxious chemical compounds 
(repellents). The way they achieve this is the following (Alberts et al,): E.coli have 
multiple flagella. When the flagella rotate counter-clockwise they all form a bundle 
allowing the cell to swim towards a certain direction, whereas when they rotate clockwise 
they fly apart, so that the cell tumbles chaotically without moving forward. In the absence 
of any stimuli the rotation changes direction with a certain frequency so that the cell 
swims smoothly in a straight line which is interrupted by abrupt, random changes in 
direction, caused by tumbling. In the presence of an attractant the rotation of the motor 
which controls the flagella will be biased towards the counter-clockwise direction, 
resulting in longer periods of smooth swimming which help the cell swim towards higher 
concentrations of the attractant. Similarly, in the presence of a repellent the rotation is 
biased towards the clockwise rotation which increases the tumbling and results in a 
change in the direction of swimming, so that in the end the cell moves away from the 
higher concentration of the repellent. 
The bias of the rotation towards either direction is controlled by the binding of the 
phosphorylated RR CheY (CheY-P) to the motor complex (fig.I-3A): binding of CheY-P 
to the motor favours tumbling. Therefore the cell chooses its fate by regulating the levels 
of CheY-P according to the environmental stimuli. The cognate kinase of CheY is CheA 
but unlike most two-component systems CheA is not a receptor. CheA is a dimer which 
binds both directly and through the adaptor protein CheW to multiple dimers of 
chemotaxis receptors (figI-3B). These receptors can sense a plethora of stimuli ranging 
from small molecules to temperature and pH and transduce the signal to CheA. 
Attractants lead to a decrease of CheA activity so that the levels of CheY-P are reduced 
and smooth swimming is favoured. Repellents have the opposite effect. Regulation of the 
level of CheY-P is completed by CheZ which increases the dephosphorylation of CheY-P 
and ensures a rapid turn-over of the signalling species, which is necessary for fast 
responses to changes in the environment. 
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(A)          (B)   
 
Fig. I-3. (A) Schematic representation of the chemotaxis pathway in E.coli. The signalling complex 
phosporylates CheY (Y) which regulates the bias of the motor rotation. Repellents increase CheA (A) 
activity leading to increase of Y-P, which favours tumbling. The system adapts to the stimuli by the 
CheB/CheR system which controls the methylation state of the signalling complex (B) Schematic 
representation of the of the signalling complex. The exact stoichiometry is receptor dimers:CheW:CheA 
dimer 7±1:3±1:1 The receptor homodimers can belong to different types of chemoreceptors. (Adapted from 
Abouhamad et al, 1998 and Stock and Levit 2000). 
 
 
However, cells should be able to sense not absolute concentrations of the chemical 
signals but rather changes in their concentration. Otherwise, for example when they 
encounter an attractant they would keep swimming and eventually move away from it or 
when they encounter a repellent they would mainly tumble and not escape from it. This 
means that when the cells are exposed to a certain concentration of a compound they 
have to adapt to it so that they can later on sense changes in the concentration and keep 
moving towards the higher concentration of attractant and away from the higher 
concentration of repellent. Adaptation takes place, within minutes (Niedhart et al), 
through the methylation and de-methylation of specific glutamate residues on the 
cytoplasmic tail of the chemotaxis receptors. Methylation is carried out by CheR and 
leads in a increase of CheA activity. De-methylation occurs through CheB, which can 
also de-amidate some glutamines to glutamates, which are also methylation targets, 
leading to a decrease of CheA activity. CheB itself is regulated by CheA through 
phosphorylation. Thus when a cell encounters a given concentration of an attractant the 
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level of CheA kinase activity will drop and the level of CheY-P will decrease leading to 
smooth swimming. However, at the same time the level of phosphorylated CheB will 
drop, leading to an increase of the methylation state of the receptor, restoring CheA 
kinase activity to the former level. It should be noted that the methylation level of of the 
receptor influences the ligand binding affinity as well. 
In order to cover the whole range of chemical stimuli E.coli have 5 chemotaxis 
receptors: two of them, Tsr and Tar, are the most abundant ones and are responsible 
mainly for amino acid sensing. Trg and Tap which are less abundant are responsible 
mainly for sensing of sugars and dipeptides respectively and Aer is responsible for 
oxygen and generally energy taxis. It should be noted that the actual number of signals 
sensed by each receptor is very high., e.g. Tar is described as the aspartate receptor, 
because it can sense aspartate as an attractant, but also has other attractants like 
glutamate, maltose (which is recognised through its complex with the Maltose-Binding-
Protein, MBP), high temperature, low pH and repellents like Ni+2 and Co2+ (Mowbray 
and Sandgren, 1998). 
The situation gets even more complicated by the fact that the chemoreceptors not only 
share some common signals, but localise together at the cell pole, forming a 
heterogeneous lattice (Maddock and Shapiro, 1993) with intrinsic properties. Within the 
lattice the stoichiometry of the complex is Receptor Homodimer:CheW:CheA dimer 
7±1:3±1:1 (Liu et al, 1997), where the homodimers could belong to different types of 
receptors. It has been shown that formation of the lattice enhances the sensitivity of the 
receptors (Duke and Bray, 1999; Sourjik and Berg, 2002; Mello and Tu, 2003) but also 
facilitates extensive cross-talking between the different types of chemoreceptors 
(Gestwicki and Kiassling, 2002,). Thus the sensing properties of each type of receptor 
within the lattice depend not only on its own expression level, but on the presence and 
relative amount of the rest of the chemoreceptors (Sourjik and Berg, 2004). Formation of 
the lattice requires CheA and CheW (Maddock and Shapiro, 1993), indicating that the 
part of the chemoreceptors involved in the lattice formation is the cytosolic domain. 
Moreover there are specific residues in this domain which have been shown to participate 
in the formation of trimers of receptor dimers (Ames et al, 2002).  
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It is worth noticing that, up to know, the assignment of recognition of a compound to a 
certain chemoreceptor has been done with single or double deletion mutants of some of 
the receptors. Taking into account the cross-talking of the receptors within the lattice, one 
could realise that past observations were actually reflecting the properties of a mixture of 
receptors under the specific experimental conditions and possibly the call of whether a 
given compound is recognised or not by a certain receptor could sometimes be wrong. As 
more data are compiled on the interactions of the receptors within the lattice, it becomes 
more and more clear that chemotaxis studies could give unambiguous results only in 
strains that express a single chemoreceptor. 
The E.coli chemotaxis signalling pathway seems a very promising system for 
engineering, since there are a lot of experimental data on it. However one of its major 
draw-backs is that it is not coupled to gene expression, which limits its applications. 
Furthermore, its complexity, the extensive cross-talking among receptors and adaptation 
are additional problems for engineering. 
The methyl accepting transducers are conserved in many prokaryotes (Nowlin et al, 
1985), but the signalling network appears to be fine-tuned for each species. A very 
interesting example is the chemotaxis network of Rhodobacter sphaeroides which carries 
more than one alleles for the che genes and has two sites of chemoreceptor localization: 
one at the cell pole, like in E.coli, or at the center of the cell. Although the che genes 
from each locus localize only at one of the two sites (Wadhams et al, 2003), the role of 
multiple che genes is even more complicated: since the cheZ gene is absent in 
R.sphaeroides the necessity for a phosphatase activity is fulfilled by the existence of an 
alternative CheY protein which acts as a phosphate sink (Armitage 1999). 
It should be noted that from the different receptor domains, the most conserved has 
been shown to be the cytoplasmic domain, whereas there is great variation in the sensing 
domain (Wuichet and Zhulin, 2003). This can facilitate the evolution of novel transducers 
which respond to new environmental stimuli and are readily incorporated in the existing 
chemotaxis apparatus. However even when all the components of the pathway are 
conserved, there are still differences, as demonstrated in the case of E.coli and S.typhi. 
The dimeric aspartate receptor (Tar) in both cases carries two ligand binding sites and 
aspartate binding is negatively cooperative. However in S.typhi a second aspartate 
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molecule can still bind, with much lower affinity, to the second site under physiological 
conditions whereas in E.coli it cannot (Biemann and  Koshland, 1994). 
Such mechanistic differences should be expected to be clarified by the crystal 
structures of the proteins. However this is far from being true in this particular case. The 
chemoreceptors have a very high helical content and only parts of them have been 
crystallized (fig.I-4) Specifically the periplasmic domain of the E.coli aspartate receptor 
(TarE) in the absence of ligand, the periplasmic domain of the S. typhi aspartate receptor 
(TarS), both in the presence and absence of ligands (for all the structures see Bjorkman et 
al, 2001) and the cytoplasmic region of the E.coli serine receptor have been crystallized 
(Kim et al, 1999).  
 
 
 
 
Fig. I-4. (adapted from Weis et al, 2003). (A) Schematic representation of a Tar dimer. The two 
subunits are shown in white and blue (B) Available crystal structures for the periplasmic domain of Tar and 
cytoplasmic of Tsr. The latter is crystallized as a trimer of dimers. (C) Model of the whole receptor based 
on the available structures. 
 
However, as will de discussed in more detail in the results and discussion sections, the 
available structures do not exhibit a significant change in the presence or absence of 
aspartate, raising the question which is the actual mechanism for signal sensing. Although 
a lot of different mechanisms have been proposed based on different techniques, with the 
most widely accepted that of the piston model (Ottemann et al, 1999), the real 
mechanism seems to be unclear as more data are compiled on the interactions between 
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receptors in the lattice. Furthermore from the vast majority of signals only for some 
attractants like aspartate, maltose and pH the actual sensing domains have been 
identified. In the case of repellents the sensing mechanism is completely unknown and it 
is only extrapolated that it occurs through binding to the receptors, from the behaviour of 
the attractants. The only proposed mechanisms for repellents is sensing of a) nickel by 
Tar through the binding of the complex Nickel and Nickel Binding Protein (De Pina et al, 
1995) b) heavy metal ions through direct binding to the Tar periplasmic region (Scott et 
al, 1993) c) aromatic compounds by binding to the pocket where 1,10-phenanthroline is 
seen in the crystal structure of the Tar periplasmic domain (Scott et al, 1993). However 
none of these hypotheses has been demonstrated and apart from the necessity of the 
nickel-binding protein for nickel taxis no binding to Tar of the respective complex has 
been shown. 
The putative structure of the whole receptor, has been generated by combining the 
crystal structures and modelling of the missing structures (Kim et al, 1999). A schematic 
representation is shown in fig.I-4. 
The linker between the second transmembrane region and the cytoplasmic domain is 
the highly conserved for bacterial tranducers HAMP domain (domain present in Histidine 
kinases, Adenylyl cyclases,Methyl-accepting proteins and Phosphatases (Aravind and 
Ponting, 1999)). The HAMP domain consists of two α-helices joined by a linker and 
appears to be crucial for signal transduction, since mutations in this region usually result 
in locked on or off transducers (Ames and Parkinson, 1988; Appleman and Stewart. 
(2003)). In the case of the chemoreceptors the HAMP domain plays an additional role: it 
is involved in the pH sensing (Umemura et al, 2002), although the exact mechanism for 
this is not known. 
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Chimeric Systems 
 
Chimeric proteins have proven to be a powerful tool both for elucidating properties of 
their parental systems but also for generating proteins with novel properties. Roughly, 
two types of chimeras have been used. 
The first type is chimeras of proteins with highly similar function and origin. The most 
profound examples of this case are the chimeras of the different E.coli chemoreceptors 
with each other. Tar-Tap and Tap-Tar hybrids (Weerasuriya et al, 1998) highlighted the 
importance of the docking site for CheB and CheR in Tar (and Tsr) and Tsr-Tar chimeras 
shed light on the region of the receptors which is responsible for pH sensing (Umemura 
et al, 2000). In all cases the plasticity of the chemoreceptors well manifested. 
The second type of chimeras involves proteins which are not closely related and their 
properties are emerging from the parental systems, without necessarily being identical. 
Examples of this case are the chimeras of the chemoreceptors Tar and Trg to the 
osmosensor EnvZ which are activated, instead of inhibited, upon ligand binding (Utsumi 
et al, 1989; Baumgartner, et al, 1994). 
Another example is the chimera of the sensor that is involved in nitrate and nitrite 
utilization, NarX and Tar (Ward et al, 2002). This chimera functions as a chemoreceptor 
which senses the ligands of NarX, nitrate and nitrite, as repellents. 
The most intriguing and extreme example is the chimera between Tar and the insulin 
receptor which is functional and is activated by Tar’s ligand, aspartate (Moe et al, 1989). 
 
 
The Taz-OmpR system 
As mentioned above, using the chemotaxis signalling pathway, for which the signals 
are known, as a “template” to engineer a signalling pathway fails at the level of coupling 
the pathway to transcription. The EnvZ-OmpR exhibits exactly the opposite problem: 
although it is coupled to transcription the exact signal is unknown. These problems can 
be circumvented by fusing the two pathways so that known signals from the first pathway 
can lead to an effect on gene expression through the second pathway. Such a fusion of the 
two pathways has already been demonstrated with the construction of Taz. 
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Taz is a chimeric receptor which consists of the transmembrane, periplasmic and 
linker region of the aspartate receptor Tar and the cytoplasmic dimerisation and catalytic 
domain of EnvZ (EnvZ-C) (Utsumi et al, 1989). In the absence of aspartate, the ratio of 
kinase/phosphatase activities of Taz is such that the level of OmpR-P is insufficient to 
activate transcription from pompC. Upon aspartate binding, the phosphatase activity is 
down-regulated, while the kinase activity remains constant, leading to an increase of 
OmpR-P and activation of transcription (Jin et al, 1993). Therefore the output of the 
pathway can be easily monitored by having a reporter gene, like GFP, expressed from 
pompC. 
 
 
 
 
Fig. I-5. The Taz-OmpR system. Taz is involved in both phosphorylation and dephosphorylation of OmpR. 
In the absence of a signal the ratio of the two catalytic activities cannot lead to sufficient OmpR-P levels for 
transcription from the pompC promoter. Upon aspartate binding the ratio changes through a decrease in 
phosphatase activity leading to transcripion from pompC, in this case of GFP. 
 
 
Fusion of the two receptors gives more advantages than simply coupling a pathway to 
transcription. Since Taz lacks the cytoplasmic region of Tar, it has at least two new very 
important properties:  
a) the methylation sites are absent and thus Taz is not subjected to adaptation which 
would take place too fast to allow a response on the transcription level. 
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b) the residues which participate in the trimer of receptors dimers and lattice 
formation are absent, suggesting that Taz probably does not take part in 
oligomerisation with the chemoreceptors and probably does not cross-talk with 
them, at least not in the manner that wild-type Tar does. 
All the aforementioned advantages could make the Taz-OmpR system appear to be 
ideal for studying the sensing properties of the periplasmic domain of Tar in an easy way, 
uncoupled from the effect of the other chemo-receptors. However things are not that 
simple, as Taz seems not to retain all of the sensing properties of the periplasmic domain 
of Tar, i.e. Taz fails to sense maltose and the sensitivity of the system for Asp is 
approximately 1000-fold lower than that of the wild-type chemotaxis signalling pathway 
(Utsumi et al, 1989; Baumgartner, et al, 1994). This could be due to various reasons like 
the fact that the adaptation machinery and lattice formation contribute significantly to the 
sensitivity of the wild type system. Moreover a subtle conformational change in the 
periplasmic domain caused by the fusion of the two proteins could alter the affinity for 
the ligands.  
It should be noted that the case of maltose is rather intrinsic. The affinity of the wild 
type Tar for the maltose-MBP complex is very low (Kd= 200 µM, Manson et al, 1985), 
but this is compensated by the high concentration of MBP in the periplasm (1 mM 
Manson et al, 1985) and the localisation of Tar, which increases the active concentration 
of binding sites. In the case of Taz, under the experimental conditions used in the original 
work on Taz, MBP might not be expressed, since OmpR-P represses expression of the 
activator of MBP expression encoded by the gene malT (Case et al, 1986). Furthermore, 
a similar decrease in affinity for maltose to that for aspartate would require an extremely 
high concentration of MBP in order to elicit a response. Therefore it is not completely 
clear if Taz actually fails to sense maltose or if it is a matter of choosing the appropriate 
conditions.  
Nevertheless, the fact that Taz still responds to aspartate makes the Taz-OmpR system 
a good “template” to build a novel pathway: the availability of the crystal structure of the 
aspartate-Tar periplasmic domain gives the opportunity to try to change ligand specificity 
through rational design and the output of the system can be optimised by building 
different gene circuits to control it.  
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Bacterial strains and plasmids 
 
The strains used are listed in table II-1. 
 
Table II-1. Bacterial strains. For the commercially available ones the supplier is given as a reference 
 
 
strain genotype reference 
AT142 F- ∆lacU169 araD rpsL relA thi flhD5301 ∆envz::Kmr Mizuno and 
Mizushima, 
1987 
RP437 thr(Am)1 leuB6 his-4 metF(Am)159 eda-50 rpsL1356 thi-1 
ara-14 mtl-1 xyl-5 tonA31 tsx-78 lacY1 F-
Parkinson 
and Houts, 
1982 
UU1250 (aer)∆1 ygjG::Gm (tsr)∆7028 (tar-tap)∆5201 zbd::Tn5 
(trg)∆100 leuB6 his-4 rpsL136 thi-1 ara-14 lacY1 mtl-1 xyl-
5 tonA31 tsx-78  
Ames et al, 
2002 
VS104 RP437 ∆cheYcheZ Sourjik and 
Berg, 2004 
VS181 UU1250 ∆cheYcheZ Sourjik and 
Berg, 2004 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ 
proAB lacIqZ∆M15 Tn10(Tetr)] 
Stratagene 
BL21(DE3) E.coli B F- dcm ompT hsdS(rB- mB-) gal λ(DE3) Stratagene 
JM110 RspL thr leu thi-1 lacY galK galT ara tonA tsx dam dcm 
supE44 ∆(lac-proAB) [F’ traD36 proAB lacIqZ∆M15] 
Stratagene 
Top10 F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 
deoR recA1 araD139 ∆(ara-leu)7697 galU galK rpsL (StrR) 
endA1 nupG 
Invitrogen 
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Plasmids used as a backbone, as a source for genes or provided by a collaborator are 
listed in table II-2. 
 
Table II-2. Plasmids. For the commercially available ones the supplier is given as a reference 
 
Plasmid ori resistance reference 
pCL1920 pSC101 Str, Spc Lerner and Inouye, 
1990  
pBAD33 p15A Cm Guzman et al, 1995 
pBluescript KS pUC Amp Stratagene 
pET-3a pBR322 Amp Novagen 
pTAK117 ColE1 Amp Gardner et al, 2000 
pCL113 p15A Cm Ames et al, 2002 
 
All receptors and the ompr genes from XL1-Blue and BL21(DE3) were cloned under 
the Plac promoter in pCL1920, which is a very low copy number plasmid (5 copies per 
cell). Plasmids pBAD33 and pET-3a were used as backbone for the reporter systems. The 
constructs built in this study are listed in table II-3. 
Plasmid pBluescript KS was used as a cloning vector because of its flexibility: it is a 
high copy number vector of relative small size, with universal primers flanking the MCS 
and therefore it is a good vector for sequencing genes and correcting/introducing 
mutations with PCR-ATW.  
Plasmid pTAK117 was provided by prof. Collins and used as a source for the gene of 
the temperature sensitive CI repressor (CIts). 
Plasmid pCL113 was provided by prof. Parkinson and used in the chemotactic assays. 
It carries Tar with the mutation S63G, which does not affect the receptor’s function, 
under the nahG promoter. Expression is induced by sodium salicylate which releases the 
plasmid-encoded NahR repressor from the promoter. 
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Table II-3. Constructs built in this study 
 
construct Short description backbone resistance
pTaz2 TaZ A160V under Plac pLC1920 Spc, Str 
pH1 H1 receptor under Plac pLC1920 Spc, Str 
pH21 H21 receptor under Plac pLC1920 Spc, Str 
pH22 H22 receptor under Plac pLC1920 Spc, Str 
pH3 H3 receptor under Plac pLC1920 Spc, Str 
pBTaz2 TaZ A160V clone pBluescript KS Amp 
pBTaz TaZ with a NcoI site  pBluescript KS Amp 
pCOR TaZ with a Pst I- Nco I cassette for the 
ligand binding domain 
pBluescript KS Amp 
pBTL TaL receptor clone pBluescript KS Amp 
pBTS TaS receptor clone pBluescript KS Amp 
pBTT TaT receptor clone pBluescript KS Amp 
pBTQ TaQ receptor clone pBluescript KS Amp 
pBTLM TaLM receptor clone pBluescript KS Amp 
pBT69L TaZ R69L receptor clone pBluescript KS Amp 
pBT69M TaZ R69M receptor clone pBluescript KS Amp 
pBT73M TaL R73M receptor clone pBluescript KS Amp 
pBTsz Tsz receptor clone pBluescript KS Amp 
pBTsarz TsarZ receptor clone pBluescript KS Amp 
pBTSNI TSNI receptor clone pBluescript KS Amp 
pBTasZ TasZ receptor clone pBluescript KS Amp 
pTL TaL receptor under Plac pLC1920 Spc, Str 
pTS TaS receptor under Plac pLC1920 Spc, Str 
pTT TaT receptor under Plac pLC1920 Spc, Str 
pTQ TaQ receptor under Plac pLC1920 Spc, Str 
pTLM TaLM receptor under Plac pLC1920 Spc, Str 
pT69L TaZ R69L receptor under Plac pLC1920 Spc, Str 
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pT69M TaZ R69M receptor under Plac pLC1920 Spc, Str 
pT73M TaL R73M receptor under Plac pLC1920 Spc, Str 
pTsz Tsz receptor under Plac pLC1920 Spc, Str 
pTsarz TsarZ receptor under Plac pLC1920 Spc, Str 
pTSNI TSNI receptor under Plac pLC1920 Spc, Str 
pTasZ TasZ receptor under Plac pLC1920 Spc, Str 
DGB33 dGFP out-of-frame from PBAD pBAD33 Cm 
pR1 dGFP under pompC pBAD33 Cm 
pR2 dGFP under pompC pBAD33 Cm 
p33 pBAD33 replacing ClaI-SacI fragment with 
a promoterless ClaI-AraC-SacI 
pBAD33 Cm 
pAatII p33 introducing an Aat II site near the end 
of araC 
p33 Cm 
pAORTcor TetR under synthetic promoter with OR1  pAatII Cm 
pR4 dGFp under pompC with overlapping 
mutant TetO1 
pBAD33 Cm 
pR5 TetR under synthetic promoter with OR1 pR4 Cm 
pR6 GFP antisense RNA under synthetic 
promoter 
pR5 Cm 
pR7 Operon fusion of CIts with dGFP pR5 Cm 
pR5C pR5 with –33 T->C in synthetic promoter pR4 Cm 
pR6C pR6 with –33 T->C in synthetic promoter pR5 Cm 
pR7C pR7 with –33 T->C in synthetic promoter pR5 Cm 
pBOX OmpR from XL1-Blue clone pBluescript KS Amp 
pBEX EnvZ from XL1-Blue clone pBluescript KS Amp 
pLOX OmpR from XL1-Blue under Plac pLC1920 Spc, Str 
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Growth Media 
 
LB (1L): 
 
Bacto-tryptone 10 g 
Bacto yeast extract 5 g 
NaCl 10 g 
 
Adjust pH to 7.0 and sterilise by autoclaving for 20 min at 15 lb/sq.in on liquid cycle. 
 
SOC (1L): 
 
Prepare 950 ml of water containing 
 
Bacto-tryptone 20 g 
Bacto yeast extract 5 g 
NaCl 0.5 g 
KCl 0.186 g 
 
Adjust pH at 7.0 and sterilise by autoclaving for 20 min at 15 lb/sq.in on liquid cycle. 
Before use add 5 ml of 2M MgCl2 and 20 ml of 1M glucose (final concentration 20 mM 
glucose). Filter sterilise using a 0.22-micron filter. Store at 4°C. 
 
Medium A 
 
Nutrient Broth (Difco) 7 g 
yeast extract 1 g 
glycerol 2 g 
K2HPO4
(K2HPO4.3H2O) 
3.7 g 
(4.85 g) 
KH2PO4 1.3 g 
water up to 1L 
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Labelling medium (1L): 
 
M9 medium 10x (1L): 
 
Na2HPO4 60 g 
KH2PO4 30 g 
NaCl 5 g 
NH4Cl 5 g 
 
Sterilise by autoclaving for 20 min at 15 lb/sq.in on liquid cycle. 
 
Trace elements 100x (1L): Dilute EDTA in 800 ml and adjust pH=7.5. Then add 
the rest and fill to 1L. 
 
EDTA 5 g 
FeCl3.6H2O 0.83 g (0.4982 g anhydrous) 
ZnCl2 0.084 g 
CuCl2.2H2O 0.013 g 
CoCl2.6H2O 0.010 g 
H3BO3 0.010 g 
MnCl2.6H2O 0.016 g 
 
Filter sterilise using a 0.22-micron filter. 
 
Labelling Medium (1L): 
 
M9 10x 100 ml  
Trace elements 100x 10 ml  
Carbon source 20% (w/v) 20 ml  (final concentration 0.4%) 
MgSO4 1M 1 ml (final concentration 1 mM) 
CaCl2 1M 0.3 ml  (final concentration 0.3 mM) 
Biotin 1mg/ml 1 ml  (final concentration 1µg/ml) 
ThiaminHCl 40mg/ml 25 µl  (final concentration 1µg/ml) 
 
Filter sterilise using a 0.22-micron filter. 
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Tryptone Broth (1L): 
 
Tryptone 10 g 
NaCl 5 g 
 
Sterilise by autoclaving for 20 min at 15 lb/sq.in on liquid cycle. 
 
 
Basic molecular biology techniques 
 
PCR 
 
The Polymerase Chain Reation (PCR) was used for amplifying DNA fragments, 
screening bacterial colonies for constructs, mutagenesis and gene construction. 
In all applications the final volume of the reaction mixture is 50 µl, containing 3 µl of 
10 mM solution of each primer and 1µl of 10 mM dNTP mix. PCR screening was carried 
out using 0.2 units of Taq polymerase, whereas for the rest applications 1-2 units of Pwo 
polymerase were used. 
 
 
 
DNA amplification 
 
The desired DNA fragments were amplified using 30-60 ng of template, for plasmid-
borne templates, or by lysing a single bacterial colony, by boiling at 98°C for 5 min in 
water, for genomic templates.  
When the primers in use introduce a restriction site, extra bases are added to the 5’ end 
of the primer to facilitate restriction. The exact number of these bases is specified for 
each restriction enzyme by its manufacturer (NEB). The procedure followed is: 
? Heating at 97°C for 2 min (Adding the polymerase in the appropriate volume of 10x 
buffer at 1.5 min)  
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? 
? 
? 
? 
? 
? 
? 
? 
denaturation at 97°C for 30 sec 
annealing at 2°C below the lowest melting temperature of the primers, as calculated 
by the manufacturer (proligo). 
elongation at 72°C for X min where X is the size of the desired fragment in kb. For 
fragments smaller than 1 kb the time used was 1 min.  
final elongation at 72°C for 10 min. 
cooling at 4°C.  
The number of denaturation-annealing-elongation cycles is 30. 
 
 
PCR-Screening 
 
PCR screening of colonies was performed as in the same way with the following 
differences: 
Single colonies were used to inoculate liquid cultures and the remaining cells were 
lysed by boiling in the appropriate volume of water for 5 min at 98°C.  
The rest of the reaction mix was subsequently added, without performing a hot-start. 
Annealing temperature is 4-6°C below the lowest melting point of the primers. 
The primers used for screening usually have a Tm=54-58°C and one of them 
hybridises on the vector backbone while the other on the construct. 
 
 
 
PCR-mutagenesis-PCR-Around-The-World (PCR-ATW) 
 
PCR mutagenesis was used to create or destroy restriction sites within cloned genes 
and to make or correct single point mutations. 
The procedure followed is the same as for amplifying a DNA fragment with the 
following differences: 
1. The amount of template is 20-40 ng. 
2. The number of cycles is 15. 
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3. The annealing temperature is 63°C, because of the way the primers are designed: 
The two primers have a complementary region which consists of the mutation(s), flanked 
by 10 bases. Each primer consists of 10 bases at the 5’ end, hybridising to the template, 
the desired mutation(s), followed by at least 30 bases, so that the 3’ end ends with a c or 
g, hybridizing to the template. The product generated is the whole vector, carrying the 
mutated DNA sequence, that is why the method is called PCR-around-the-world. 
After the PCR, 1µl (20 units) of DpnI is added directly to the reaction mix and it is 
incubated o/n at 37°C, in order to degrade the template. DpnI will digest only methylated 
template, thus not the PCR product. Therefore the strain used for isolating the template is 
usually XL1-Blue or Top10 which have the methylating enzymes.  
 
 
Gene construction by PCR 
 
The exact procedure varies for different constructs. 
Very small DNA fragments were constructed by using two complementary primers 
and filling-in with Pwo polymerase, following the same general protocol as for DNA 
amplification. 
Constructs which are the fusion of two DNA fragments were built as follows: 
Each fragment is amplified for 10 cycles (if it is plasmid-borne or constructed by 
primers as described above) or for 30 cycles (if it comes from genomic DNA). The 
primers used are such, that the 3’ reverse primer of the first fragment contains a 
complementary sequence to the 5’ forward primer of the second fragment, marking the 
fusion of the two fragments. (fig.II-1). The overlap is such that the melting temperature is 
quite high (above 63°C). 
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Fig. II-1. Fusion of two genes by PCR. The two genes are amplified by using a 3’ primer for the first 
gene and a 5’ primer for the second one that contain the sequence at the fusion point and are 
complementary to each other. When the products of the two PCR reactions are mixed, under PCR 
conditions, the top strand of the first reaction will hybridize to the bottom strand of the second and the gaps 
will be filled-in by the polymerase leading to the full-length desired product. Including the external 5’ and 
3’ primers (single colour rectangles) results in amplification of the latter product. 
 
 
Aliquots from both reaction mixtures are directly mixed in a new tube, with fresh 
dNTPs, polymerase and the 5’ forward primer of the first fragment and the 3’ reverse 
primer of the second. The aliquots are such that the ratio of the aliquots’ volume is 
roughly within the range of  the ratio of the sizes of the two fragments e.g for the fusion 
of a ~150bp synthetic promoter to TetR (~600bp) 0.5µl of the promoter PCR mix and 
1.5µl of the TetR PCR mix were used. 
When more than two fragments needed to be fused together it was necessary to make a 
variation in the method, since simple mixing of all the PCR products together didn’t 
result in great (if any) amounts of the desired product. For example for the construction 
of the ligand binding domain of the mutant receptors 8 overlapping primers were used. 
Mixing of all the 4 PCR products or of only 2 fusion products didn’t was unproductive 
(fig.II-2A) and it was necessary to make 3 fusion products which were then combined 
and amplified with external primer (fig.II-2B). 
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Fig. II-2. Fusion of four DNA fragments by PCR. (A) Fusion two-by-two did not give the desired product 
(B) Fusion two-by-two facilated by bridging with a fusion product of genes 2 and 3. 
 
 
In all applications PCR products were cleaned using the Qiaquick PCR purification kit 
(Qiagen), except when there were by-products. In those cases the desired product was 
purified by gel-extraction, after agarose gel electrophoresis, using the Gel-Extraction kit 
(Qiagen). 
 
 
Restriction 
 
Purified PCR products or plasmids were subjected to o/n restriction at 37°C. 
Whenever possible double digestion was preferred. Otherwise restriction was done 
sequentially according to the manufacturers recommendations (NEB). Plasmids were 
simultaneously dephosphorylated, by adding 1 unit of Shrimp Alkaline Phosphatase 
(SAP) in the reaction mixture. The amount of restriction enzyme(s) and SAP added was 
such that the total amount of added glycerol was below 5% of the final volume.  
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Enzymatic reaction clean-up 
 
Products of restriction reactions were purified using the Qiaquick PCR purification kit, 
following the manufacturer’s protocol for enzymatic reaction clean-up, when the 
restriction yielded undesirable fragments smaller than 80 bp. When the undesired 
products were higher than 80 bp the desired products were separated by preparative AGE 
and purified with the Qiagen gel-extraction kit. 
 
 
Ligation 
 
Ligations were performed o/n at 16°C using 1 unit T4 DNA ligase, from Roche, in a 
total volume of 20 µl. The amount of vector used was 200- 400 ng and the molar ratio of 
insert to vector was always 3:1. The amounts of restricted vector and insert that were 
needed for the reaction were calculated after determining spectroscopically the 
concentration of the purified restriction products, with an eppendorf spectrophotometer. 
 
 
Plasmid isolation 
 
The appropriate kit was used for plasmid isolation, depending on the copy-number and 
the desired quantity. For high copy number plasmids the Qiagen Mini-prep kit was used, 
following the manufacturer’s protocol, with the following differences: 
-the optional wash with PB was always done 
-the PE was left on the column for 2-5 min when the preparation would be treated with 
salt sensitive restriction enzymes. 
-the DNA was finally eluted with the kit’s Elution Buffer (EB). Water was used for 
elution only when the preparation would be used for sequencing reactions. When the 
preparation would be used for restriction reactions with salt-sensitive restriction enzymes, 
the DNA was eluted either with water or diluted EB 1:1 to achieve higher yield. 
Materials and Methods 25
Medium copy and low copy number plasmids were isolated using the Qiagen High-
Speed midi and maxi kits according to the manufacturer’s instructions. The quality of the 
preparation was usually not adequate for sequencing reactions and an extra purification 
step was applied, using the columns from the mini-prep kit and the clean-up protocol 
from the Qiaquick PCR purification kit. 
 
 
 
 
 
 
 
 
Competent cells-Transformation 
 
All ligation products and provided vectors were transformed in chemically competent 
XL1-Blue cells, purchased from Stratagene, or Oneshot Top10 cells, purchased from 
Invitrogen Life Technologies. Transformations were carried out following the 
manufacturer’s instructions with the following differences: a) β-mercaptoethanol was not 
used b) the heat-shock was performed in 2-ml reaction tubes c) 20 µl of competent cells 
were used per 10 µl of ligation mixture and 10 µl per 1 µl of plasmid preparation. 
Transformation of other strains with plasmids was performed with either of the two 
following methods: 
 
a)TSS method 
 
The TSS method is a variant of the method described by Chung et al (1989) for 
preparing chemically competent cells. The transformation efficiency achieved with this 
method is not very high (in the range of 105) so it is appropriate only for transforming 
with plasmids but not ligation mixtures.  
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Materials 
 
2xTSS (100ml) 
 
Bactotryptone 2 g 
Bacto yeast extract 1 g 
NaCl 2 g 
PEG 3350 (I 8000) 20 g     (20%) 
DMSO  10 ml   (10%) 
MgSO4.7H20 1.23-2.46 g  
(50-100 mM) 
 
Mix vigorously for at least 45 min, until the solution is clear. 
Adjust pH to 6.50 
Filter sterilise using a 0.22-micron filter. 
 
Experimental procedure 
? 
? 
? 
? 
? 
? 
? 
? 
A fresh overnight culture is diluted 1:100 into pre-warmed LB and incubated at 37°C 
at 225 rpm until it reaches an OD600= 0.3-0.4. 
Add equal volume of ice-cold 2xTSS and mix gently. 
For long term storage cells are immediately frozen in dry ice/ethanol and stored at       
-70°C. 
For transformation a 100 µl aliquot is placed in a cold 2 ml reaction tube containing 
50-300 ng  plasmid DNA and mix gently. (when using frozen cells, the cells are 
thawed on ice and used immediately). 
Incubate the mix at 4°C for 5-60 min, usually 30 min. 
Add 900 µl LB +20 mM glucose (~20 µl of 20% solution). 
Incubate at 37°C (225 rpm) for 1 h. 
Plate different quantities of the transformation mix ranging from 5 µl to the total 
transformation mix on the appropriate antibiotic plates, using sterile glass beada. 
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b) TB method 
 
This method is a variant of the method described Inoue et al (1990)  
 
Materials 
 
TB 1x (100 ml) 
 
10 mM HEPES pH 6.7. 0.2383 g 
15 mM CaCl2.2H2O 0.22053g  
250 mM KCl 1.8625 g 
55 mM MnCl2.2H2O 0.89034 g 
 
Mix all component except MnCl2 and adjust the pH to 6.7 with KOH. Then add the 
MnCl2 and filter sterilize the mixture using a 0.22-µm filter. 
 
Experimental procedure 
 
? 
? 
? 
? 
? 
? 
? 
? 
Inoculate 3 ml LB medium with a colony of the appropriate E. coli strain and 
incubate the culture overnight at 37°C. 
Add from the overnight culture 150µl (3:500) to 25 ml SOC medium and incubate the 
culture at 37°C up to OD600=0.4-0.6. 
Chill the culture for at least 10 min on ice.  
 
In the following steps, the cell suspension should be kept on ice as much as possible.  
 
Centrifuge the cell suspension for 10 min at 3,500 at 4°C.  
Gently resuspend the pellet in 5 ml ice-cold TB buffer. 
Incubate the cell suspension on ice for 10 min. 
Centrifuge for 10 min at 3,500 rpm at 4°C. 
Gently re-suspend the pellet in 930 µl ice-cold TB buffer and add 70 µl DMSO. 
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? 
? 
? 
Incubate the cell suspension on wet ice for at least 10 min. 
Aliquot the cell suspension at 100 µl per 2 ml reaction tube. 
Shock-freeze the cell suspension in liquid nitrogen and store the tubes at -80° C* or in 
liquid nitrogen or use directly. 
 
*At -80°C the cells will be competent for at least 6 months. In liquid nitrogen they will 
stay competent indefinitely. 
 
This protocol gives chemically competent cells of the efficiency as commercially 
available ones (~108) and can be used for any kind of application. The transformation 
procedure from this point on is the same as described for the commercial competent 
strains. 
 
 
 
Agarose Gel Electrophoresis (AGE) 
 
AGE was used for visualising and isolating DNA fragments (PCR products, restriction 
products) and plasmid preparations using TBE-gels. 
 
TBE 5x (1L) 
 
Trizma base 54 g 
Boric acid 27.5 g 
EBTA 0.5M pH=8.0 20 ml 
 
The percentage of agarose used, depended on the size of the DNA fragments, although 
for preparative AGE, 0.7% agarose was preferred in order to minimise the amount of 
agarose in the sample during the gel-extraction procedure. 
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Poly-Acrylamide Gel Electrophoresis under denaturing conditions (SDS-PAGE) 
 
Cell lysates were analysed by SDS-PAGE with Criterion pre-cast gels (Biorad) Tris-
HCl 15%. Gels were run at constant 170 V for 1h. 
 
Loading buffer 2x (8ml) 
 
H2O 3.8 ml 
0.5 M Tris-Cl pH=6.8 1.0 ml 
glycerol 0.8 ml 
SDS 10% 1.6 ml 
β−mercaptoethanol 0.4 ml 
bromophenol blue 1% 0.4 ml 
 
 
Running Buffer 10x (1L) 
 
Tris 30.2 g 
glycine 188 g 
SDS 10 g 
H2O up to 1L 
 
Visualization of the proteins was done with Western Blotting. 
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Western Blotting 
 
Materials 
 
Transfer buffer 10x  without EtOH (1L) 
 
Trizma 30 g 
Glycine 144 g 
 
Transfer buffer 1x +EtOH (1L) 
 
Transfer buffer 10x 100 ml 
EtOH 200 ml 
water To 1L 
 
PBS (1L) 
 
NaCl 8 g 
KCl 0.2 g 
Na2PO4 1.44 g 
KH2PO4 0.24 g 
 
Adjust pH to 7.4 with HCl. Sterilise by autoclaving for 20 min at 15 lb/sq.in. on liquid 
cycle. 
 
PBST (1L) 
 
PBS 1 L 
Tween 20 50 µl (0.05%) 
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Experimental procedure 
 
Western Blots were performed using the Criterion Blotter system from Biorad, 
according to the manufacturer’s instructions. However, optimal transfer conditions were 
constant current at 380 mA for 26 min. 
After the transfer, the nitrocellulose membrane was washed with water and stained 
with Ponceau S Solution (Sigma), in order to visualise the total amount of protein in each 
lane. Background staining was removed by washing with de-ionised water. The 
membrane was then scanned with an Agfa Duoscan f40 scanner.  
The stain was subsequently removed by washing with PBS. The membrane was 
blocked at RT for 1h with 5% milk in PBST and then exposed to the primary antibody for 
1h at RT and to the secondary antibody, which is for 45 min. The primary antibody was 
monoclonal anti-GFP from Roche, and the secondary antibody was peroxidase-
conjugated donkey anti-mouse purchased from Jackson Immuno Reasearch Laboratories. 
Each step with an antibody was followed by two 10 min washes with PBST. 
After the final wash, GFP bands were visualised with the ECL Western blotting 
analysis kit from Amersham Biosciences and the exposed films were scanned. Using the 
program IQMac, the number of pixels for each band on the film was determined and then 
divided by the number of pixels from the total-protein stain of the corresponding lane. 
Both values were first corrected for background (by subtracting the number of pixels of 
membrane/film corresponding to the same area as the lane/band) to adjust for differences 
in the amount of protein transferred in each lane. The values obtained were subsequently 
normalised to the value for the control cells. 
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Expression Assays  
 
Osmotic shock assay for the EnvZ-OmpR system 
 
A single colony of the desired strain was used to inoculate a pre-culture in medium A, 
supplemented with the appropriate antibiotics. Cells were grown o/n at 37°C and 200 µl 
of this culture were used to inoculate 50 ml of fresh medium A with antibiotics (low 
osmolarity conditions) and 50 ml medium A supplemented with 0.3M NaCl (high 
osmorality conditions). The cells were allowed to grow at 37°C until mid-logarithmic 
phase and then were harvested and lysed by boiling with loading dye at 98°C for 10 min. 
Samples were subsequently analysed by SDS-PAGE and Western blotting. 
 
 
 
Compound screening assay for the Taz-OmpR system 
 
A single colony of the desired strain was streaked on an appropriate antibiotic plate 
and grown o/n at 37°C. Multiple colonies from this plate were used as the inoculate for a 
pre-culture in labelling medium in a flask 10x bigger than the culture volume, i.e. 4 ml in 
a 50 ml falcon tube. Cells were grown o/n at 37°C  and 200 µl from this culture are used 
to inoculate 50 ml of fresh labelling medium with the appropriate antibiotics in a 500 ml 
flasks. Cells were grown at 200-230 rpm at 37°C until they reach an OD600≈ 0.200 and 
then aliquoted into 15 ml falcons containing stock solution of the compound dissolved in 
labelling medium. The amount of stock was such that the final concentration of the 
compound tested would be 5 mM. The cells were allowed to grow for 1 h and then were 
harvested and lysed by boiling with loading dye at 98°C for 10 min. 
Unlike the osmotic shock assay, exposing growing cells to the compound, instead of 
inoculating fresh medium which already contains the putative signal, was necessary 
because in the latter case cells would show a longer, by several hours, lag phase 
compared to the control cells. Moreover since the compounds are amino acids, short time 
exposure reduces the amount of amino acid that is metabolised, keeping its concentration 
Materials and Methods 33
constant at the desired value. It should be noted that the system uses the chromosomal 
ompr gene which is under the control of CRP (Huang et al, 1992). Therefore a relatively 
short exposure time to metabolizable compounds could give more clear answers than 
growing the cells in the presence of the compound, since the level of OmpR should not 
change dramatically in 1h, provided that its half-life is not within the order of magnitude 
of the exposure time.  
 
 
Chemotaxis assays 
 
Chemical-in-plug assay 
 
The chemical-in-plug assay was done as described by Tso & Adler (1974) with the 
following differences: Cells were grown o/n at 30ºC in tryptone broth containing the 
appropriate antibiotic and 0.7µM sodium salicylate, for cells carrying pCL113, in order to 
express Tar. This pre-culture was used to inoculate 100 ml (or 50 ml) of fresh medium at 
1:100 and grow to an OD600<0.600 (usually 0.500). Cells were spun down in 50 ml 
falcons at 4000 rpm for 7 min at RT (i.e. 24°C), the supernatant was decanted and the 
cells were resuspended in a couple ml of Chemotaxis Buffer (CB; 10 mM phosphate 
buffer pH=7.0, 0.1 mM EDTA, 10 mM lactic acid),  by gently pipeting up and down. 
Vigorous handling of the cells was avoided in order to maintain the integrity of the 
flagella. CB was added up to a volume of 50 ml, the cells were spun down again under 
the same conditions and resuspended in the remaining CB in the tube after decanting the 
supernatant. CB was added so that the final volume of the cell suspension was 1 ml. 
The cell suspension was mixed with 24 ml 0.3% bacto-agar in CB, which was pre-
cooled at 40°C, and poured into a plate which already contained the plugs with the 
chemical. The plate was incubated for 1h at 30°C and then photographed. Plugs were 
prepared by using test tubes (16 mm diameter) to cut cylinders out of plates with the 
desired concentration of each chemical in 2% bacto-agar containing CB. 
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Swarm plates 
 
Swarm assays were done by inoculating semi-solid agar (0.3%) containing different 
concentrations of the chemicals tested (and 1.4 µM sodium salicylate to induce 
production of Tar from plasmid pLC113) with colonies from fresh o/n LB plates. The 
plates were incubated for 25 h at 30°C and then examined for swarm formation. 
 
Preparation of the plates 
 
10x M63 salts for 100 ml: 
 
KH2PO4 3 g 
K2HPO4.3H2O 7 g 
(NH4)2SO4 2 g 
FeSO4
(FeSO4.7H2O) 
0.5 mg (10µl from 50mg/ml solution which is  
0.250g/5ml or 0.519g/5ml heptahydrate) 
 
Filter sterilise. The ferrous solution should be freshly prepared because it is not stable. 
 
 
For 1L for plates 
Flask A 500 ml Water 
 6 g agar 
Flask B 100 ml 10x M63 salts 
 2g glycerol 
 2 ml Thiamine 50 mg/ml  
 1 ml 1M MgSO4
 8 ml mix L-Thr, His, Leu, Met, 5 mg/ml each 
 390 ml Water (up to 500 ml) 
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Flask A is sterilised by autoclaving and Flask B by filtration with a 0.22-micron filter. 
 
For each plate 12.5 ml of Flask B contents supplemented with the appropriate 
antibiotic, sodium salicylate and the appropriate amount from a stock solution of the 
chemical in water, were mixed with 12.5 ml of pre-cooled at 40ºC Flask A contents and 
poured into petri-dishes. 
 
 
FRET experiments. 
 
FRET experiments were carried out in collaboration with Dr. V. Sourjik in the 
University of Heidelberg (ZMBH), as described in reference Sourjik and Berg, 2004, 
with the difference that experiments were performed on Zeiss Axiovert 200 microscope 
using a 75 Watt super-quiet Xe-lamp (Hamamatsu) for illumination. 
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Results 36
Construction and testing of the core reporter system. 
 
Regulation of our reporter system is based on the OmpR-P-OmpC system. The pompC 
promoter has three binding sites for OmpR-P, C1, C2 and C3 with the most upstream 
being C1 (Mizuno and Mizushima, 1986). The affinity for each site is decreasing in the 
order C1>C2>C3 with the affinity for C3 being more than 2 orders of magnitude lower 
than that for C1 (Head et al, 1998), when C3 is considered as an independent unit. 
However in the context of all three binding sites, binding of OmpR-P is cooperative, 
lowering the Kd for the OmpR-P-C1-C2-C3 complex to one order of magnitude higher 
than C1 (Head et al, 1998). Under physiological conditions the concentration of OmpR-P 
and its affinity for C1 (Cai and Inouye, 2002) are such that C1 should be always 
occupied, even at low osmolarity. Transcription from the promoter should be activated 
when the concentration of OmpR-P increases and the binding of additional OmpR-P 
molecules is facilitated by the co-operativity with the bound OmpR-P moiety at C1. 
Apart from the activation sites, pompC carries 9 sites for the Leucine-responsive-protein, 
Lrp, spanning a region from upstream the promoter to the beginning of the coding 
sequence of OmpC (Ferrario et al, 1995). Lrp is a decahexamer which dissociates into 
octamers in the presence of Leucine (Chen et al, 2001) and can act both an activator and 
repressor of a large number of metabolic operons (Calvo et al, 1994). It has been shown 
that Lrp is a repressor for OmpC expression (Ferrario et al, 1995). 
 
 
 
Fig. III-1. The core pompC promoter that was cloned. In boxes are shown the –109 and +90 of the 
promoter (with respect to the transcription initiation site). The promoter forms a hairpin depicted by the two 
convergent arrows and contains three complete Lrp binding sites and a half Lrp site. The gfp gene is 
expressed with the first four amino acids of pro-OmpC and two amino acids encoded by the Bgl II site and 
an extra base (lower case) introduced to keep the correct reading frame 
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The core of the reporter system consists of a destabilised GFP, GFP(LVA)), which has 
a half-life of 40 min (Andersen et al, 1998) and a minimal pompC. The minimal pompC 
contains only the three binding sites for OmpR-P and spans the region from –109 to +90. 
This means that the SD and first 4 amino acids of pro-OmpC are kept, but also 4 out of 
the 9 binding sites for the Leucine responsive protein, Lrp, are kept as well (fig. III-1). 
The simple reporter system was constructed as follows: 
GFP(LVA) was created by amplifying GFPmut3 from Clontech using a 5’ primer 
which carries sequentially a KpnI and Bgl II site and a 3’ primer which carries the 
signalling sequence for the SsrA pathway (RPAANDENVLVA), targeting GFP for 
degradation (Andersen et al, 1998), and an Xba I site. It was cloned to the medium copy 
vector pBAD33 using Kpn I and Xba I, giving construct pGDB33. Since pBAD33 did not 
have a Bgl II site, the one inserted together with the PCR fragment is a unique site on 
pGDB33. As mentioned above GFP(LVA) starts with the first four aa (including the 
initial Met) of pro-OmpC but also with two extra aa which correspond to the introduced 
Bgl II site plus a g-c bp which was necessary to keep the coding sequence of GFP(LVA) 
in the correct reading frame.Thus the exact sequence of the N-terminus of GFP (LVA) is 
MKVK-DL-R. 
The minimal pompC was amplified from BL21(DE3) having ClaI and Bgl II sites at 
the ends. Attempts to fuse the pompC PCR product to GFP(LVA) or to do a three-
fragment ligation (pompC+GPF(LVA)+pBAD33) failed, so it was necessary to clone 
pompC into pDGB33. By using ClaI and Bgl II, the araC gene and the PBAD promoter are 
replaced by pompC (fig. III-2). 
 
 
Fig. III-2. Construction of pDGB33 and pR1. 
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This simple reporter was named pR1. Before assembling the whole pathway, the 
ability of pR1 to report changes in OmpR-P was tested using the wild-type EnvZ-OmpR 
system. As a first choice XL1-Blue was picked as a host strain, since it was the strain 
used for cloning and according to the supplier it should be wild-type for this system. 
Despite the fact that the sequence of the construct was correct there was no regulation by 
osmotic pressure; the system was always in the ON state. To test if there was an element 
in the plasmid that resulted in unregulated expression, the pompC-GFP(LVA) construct 
was extracted from pR1 with Cla I-Xba I digestion and sub-cloned into vector pET-3a, 
resulting in construct pR2. Vector pET-3a is a pBR322 derivative and thus the copy 
number should be around 20 and not differ too much from pR1 which should have copy 
number 10-15 (p15A origin of replication). Transforming BL21(DE3) cells with pR1 or 
pR2 resulted in a reporter system regulated by osmotic pressure (fig.III-3) suggesting that 
the observed discrepancy in XL1-Blue was probably due to something intrinsic in the 
host strain. 
 
 
 
Fig.III-3. Western blots of strains XL1-Blue and BL21(DE3) carrying the simple reporter system pR1 or 
pR2  which were grown in medium A with or without 0.3M NaCl for different time frames. pR1 is not 
regulated in XL1-Blue neither in logarithmic nor in stationary phase. However both pR1 and pR2 are 
regulated in the logarithmic phase. 
 
 
In order to account for this observation the ompr and envz genes from XL1-Blue were 
cloned and sequenced. The sequence of the EnvZ protein is exactly the same to the one in 
the Swiss-Prot databank and thus can be excluded as the cause for unregulated GFP 
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expression. OmpR was found to carry the single-point mutation D183Y. However when 
it was cloned into the low copy number pCL1920 and expressed in BL21(DE3) in the 
presence of pR2, GFP expression was still regulated which means that the specific 
mutation does not result in a constitutively active OmpR (fig.III-4) Therefore the 
observed unregulated expression of GFP in XL1-Blue should be due to a third, 
unidentified, component that interacts with the EnvZ-OmpR system. 
 
 
 
Fig.III-4. Western blots of BL21(DE3) cells carrying pR2 and expressing OmpR from either 
BL21(DE3) or XL1-Blue from plasmid pLC1920. Cells were grown for 4 h in medium A with or without 
0.3M NaCl 
 
In fig. III-3 the o/n activation of the EnvZ-OmpR system in BL21(DE3) is also shown: 
cells grown have the same GFP expression level regardless of the osmolarity of the 
medium. 
 
 
Construction of Taz and design of fusion variants 
 
It has been shown for the chimeric receptor Trz, which is the respective chimera of the 
sugar chemoreceptor Trg and EnvZ, that high expression levels of chimeric receptor 
reduce the sensitivity of the system (Baumgartner et al, 1994). Therefore Taz was cloned 
in the very low-copy number vector pCL1920 under Plac, in order to avoid over-
expression. Taz was constructed by amplifying the respective fragments of the two 
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receptors, using BL21(DE3) as a source and fusing the PCR products as described in 
Materials and Methods. Taz was cloned using Hind III and BamH I. The starting codon 
of Tar was omitted and the start of the lacZ gene in the vector was used as a start of the 
protein. In order to keep the reading frame correct an extra g-c bp  had to be added after 
the Hind III site so that the exact sequence of the N-terminus is MTMIPTS-L-IN.  
The clone used for the study carries the mutation A160V, where the numbering 
corresponds to the sequence of wild-type Tar, but it seems to have no effect on the 
receptor: even when the mutation is corrected the behaviour of the receptor stays the 
same (data not shown). 
Since the sensitivity of Taz is much lower than that of Tar, we decided to test if 
shifting the point of fusion of the two receptors could change in a favourable way the 
sensitivity of the chimera.  
 
 
 
Fig.III-5. (A) Sequence alignment of EnvZ and its closest homologue histidine kinases with Tar. (B) 
Close up of the alignment for EnvZ and Tar showing the position of the HAMP domain of both receptors 
and the Hpt-box in EnvZ. Arrows indicate the point of fusion for the different chimeras. The amino acids 
(HM) which encode the common NdeI site used originally for the construction of Taz are shown in frame. 
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Based on the sequence alignment of the two receptors (fig.III-5), three new points were 
chosen and the three additional chimeric receptors (H1, H2 and H3) were constructed as 
Taz with the following differences: 
? 
? 
? 
H1 contains the EnvZ linker instead of the Tar linker and the fusion is done at the 
conserved Pro219 of Tar. 
H2(1) contains half the linker from Tar and half from EnvZ, having the fusion at 
the conserved Gly233 of Tar. One of the clones which lost the translation stop 
codon and included 50 additional aa at the C-terminus, named H2(2), was also 
tested. 
H3 contains the linker and part of the first cytoplasmic α-helix of Tar, having the 
fusion just before the Hpt domain of EnvZ between Thr266 of Tar and Asp233 of 
EnvZ  
 
 
Testing Taz and the fusion variants. 
 
AT142 cells carrying the pR2 reporter were transformed with plasmids carrying Taz 
or either of the three variant receptors and the H2(2) clone. These cells were exposed to 5 
mM of L-aspartate at 37ºC for 1h as described in the Materials and Methods section and 
analysed by SDS-PAGE and Western blotting. AT142 have the flhD5301 mutation and 
therefore should not express Tar and most of the chemotaxis genes (Liu and Matsamura, 
1994).However, even if there is a small level of the wild-type receptors being expressed, 
Taz contains the dimerization domain of EnvZ which is enough for the formation of 
homodimers (Tomomori et al, 1999) and lacks the cytosolic part of Tar which contributes 
to the formation of higher order structures (Maddock and Shapiro, 1993; Ames et al, 
2002). Furthermore, it has been shown that autophosphorylation of EnvZ-C occurs only 
in trans within a dimer and phosphorylation between two different dimers is not possible 
(Cai and Inouye, 2003). Therefore it is safe to assume that there is no formation of 
hetero-dimers and the only active receptor species for the system under investigation is 
the Taz homodimers. 
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As show in fig.III-6 cells carrying Taz respond in the desired way, whereas cells 
carrying H1, H2(1), H2(2) result in almost no GFP expression while H3 is not regulated 
by Asp and seems to be constitutively active showing elevated GFP expression, 
compared to Taz. The behaviour of cells carrying H1, H2(1), H2(2) could either reflect a 
defect of these receptors in the phospho-transfer reactions or a problem of their stability 
and expression. Since there seems to be a very small level of GFP expression the former 
seems to be the most probable explanation. In either case the fusion variants are 
unsuitable for further analysis. 
 
 
 
Fig.III-6. Western blot of AT142 cells carrying pR2 and the respective receptor in pCL1920 exposed 
for 1h to 5 mM L-aspartate. 
 
It should be noted that much later from this study,  similar fusion variants were shown 
by Zhu and Inouye (2003) to exhibit the same behaviour as in our case and for some 
seemingly inactive receptors, like Tez1, activity could be restored by mutations in the 
linker (in the case of Tez1 Pro185Gln). These results illustrate the exquisite sensitivity of 
the chemotactic receptors to small conformational changes, but also the importance of the 
HAMP domain for effective signal transduction: apparently not only the register of the 
helices in the HAMP domain is important but also the exact sequence, since the inactive 
H1 has the same register with one of the restored Tez1 mutants but different parts of the 
Tar and EnvZ sequences. 
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Construction of other reporter systems 
 
Construct pDGB33 was used as a template to construct more complex reporter 
systems, in a sequential manner, resulting in a complex construct whose components are 
in a cassette mode and can be easily exchanged (fig.III-7). 
 
 
 
Fig.III-7.  (A) Schematic drawing of the different reporter systems; pR1 and pR2 have the GFP under 
the minimal pompC (green), pR4 has the pompC overlapping with a TetO1 variant (cyan), pR5 expresses 
also TetR (cyan) from a synthetic promoter that has the OR1 site of the CI repressor (yellow), pR6 yields a 
200 bp anti-sense RNA for GFP instead of TetR and pR7 expresses a temperature sensitive CI as a 
transcriptional fusion to GFP. (B) Schematic drawing of the pR7 construct. Each fragment is flanked by 
restriction sites so that it can be readily exchanged. The XbaI site at the end of the construct is dam 
methylation sensitive allowing for discrimination between the two sites flanking CI. The rrnB terminator 
was not included in the initial constructs. 
 
 The first intermediate construct is pR4 which was constructed like pR1 with the 
difference that pompC was amplified using a 5’ oligo which contained a TetO1 operator, 
overlapping with 3 bp of the C1. In order to avoid changing the C1 sequence, a mutation 
in respect to the TetR DNA binding sequence was allowed in the overlapping region, 
which should reduce the repressing ability of TetR (from Tn10) to 80% of that achieved 
with the wild-type sequence (Sizemore et al, 1990; Wissmann et al, 1988). The exact 
sequence of the mutant TetO1 site is shown in fig.III-8. This position was chosen for the 
TetO1 operator because there is no other position where it could be placed and compete 
with OmpR-P binding. Moreover since the affinity of OmpR-P is highest for C1 (Kd=7.7 
± 4.8 10-9 M, Head et al, 1998) and its binding to the three sites upstream from the 
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promoter is  cooperative and done in a hierarchical manner (Rampersaud et al, 1994), 
competition with TetR for this site should determine the occupancy of the rest of the sites 
and activation of transcription. 
 
 
 
Fig.III-8. Promoter pompC with an overlapping TetO1 variant site. The TetO1 site is shown in red, the 
3 bp overlap with the C1 site is shown in a box and the base that reduces the TetR binding affinity is shown 
in black. 
 
The affinity of the TetR for the tetO1 operator is much higher (Κδ≈10-11 Μ, Orth et al, 
2000 ) than the one of OmpR-P for C1 so even with the mutation the strength of the 
interaction should be sufficient for competition. In fact if TetR binding is too strong, its 
active concentration can be modulated by adding traces of aTC. It should be noted that 
Sac I- Bgl II sites were used, instead of the Cla I-Bgl II, for cloning the tetO1-pompC into 
pDGB33. This means that the araC gene and PBAD promoter are still present (figIII-9)  
 
 
 
 
Fig.III-9. Construction of pR4. In contrast to pR1, pR4 retains the PBAD promoter and araC gene. 
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However there should be no read-through transcription from PBAD, because it should 
be effectively repressed by AraC and within the pompC sequence there is a secondary 
structure which can act as a transcription termination signal (Mizuno et al, 1983).  
The tetR gene from Tn10 from XL1-Blue was amplified and fused by PCR to a 
synthetic promoter which carries the OR1 site (Li et al, 1997) for the CI repressor 
between the –35 and –10 regions. The exact sequence of the promoter is shown in fig.III-
10.  
 
 
 
Fig.III-10. Sequence of the synthetic promoter for pR5, pR6 and pR7 constructs. The OR1 site is 
shown in red and the beginning of the tetR gene in blue. The silent mutation that was introduced in the 
second codon of tetR in order to destroy the XbaI site is shown in a box. In the –35 region, above the 
sequence, is shown the mutation that was also studied 
 
In the construction the last base pair of the second codon of the tetR gene has been 
changed so that the XbaI site which existed in the wild-type sequence is lost, without 
changing the protein sequence. This was necessary in order to keep the Xba I site and the 
end of gfp unique. The SD sequence chosen provides moderate translation efficiency 
(Gardner et al, 2000). The different parts of the construct (promoter, SD, repressor gene) 
are thus cloned in a cassette form so that each one can be readily replaced according to 
the needs of the system. 
All attempts to clone the synthetic promoter-tetR construct in pR4 gave clones with a 
lot of mutations and deletions, destroying the synthetic promoter. Since this promoter 
would be separated only by 30 bp from the C1 site, it could be possible that the super-
coiling accumulated by the two divergent promoters (pompC and the synthetic one) could 
have a deleterious effect for the cells – maybe by interfering with plasmid replication 
and/or expression of the antibiotic resistance gene. 
In order to test this hypothesis a spacer of ~700 bp was introduced between the two 
promoters, because it has been shown that the half-length of transcription supercoiling 
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wave is ~800 bp (Krasilnikov, et al, 1999). As a spacer the promoter-less araC gene was 
chosen so that the sequence is as close as possible to the original one. The construction 
involved several steps since there were no available restriction sites for direct cloning. 
The procedure was the following: the coding sequence of araC was amplified from the 
original pBAD33 plasmid having SacI-ClaI sites at its ends and cloned into pBAD33, 
resulting in p33. An AatII site was introduced by PCR-ATW near the end of araC 
resulting in pAat. Finally the PCR fusion of the synthetic promoter to TetR was 
introduced into pAatII by cloning with AatII and ClaI (fig.III-11).  
 
 
 
Fig.III-11. Construction of the intermediate pAORTcor. The araC gene is shown in orange when it has 
its native promoter and in red when it is promoterless. The blue and brown boxes correspond to the Cm 
resistance gene and origin of replication respectively. The ORTetR rectangle corresponds to the synthetic 
promoter-tetR construct and the trapezoid to the rrnB terminator 
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In this construct the rrnB T1 terminator (Artsimovitch et al, 2000) was also included 
to ensure cessation of transcription before the origin of replication. The resulting 
construct, pAORTcor, was sequenced and the correct clone was used to sub-clone the 
SacI-ClaI fragment into pR4, resulting in pR5 (figIII-12). 
 
 
 
Fig.III-12. Construction of pR5. The red arrow corresponds to the promoter-less araC gene, the yellow 
(OR) to the synthetic promoter and the cyan to tetR. 
 
 The putative toxicity of the construct was not completely abolished, possibly because 
the spacer was not sufficiently long, but it was low enough to allow cloning and 
maintenance of the correct sequence-after three passages the construct was sequenced 
again and there were no mutations. 
Apart from the desired sequence, a clone with a promoter with a T->C mutation in the 
–35 region (pR5C) was obtained. Since this mutation should reduce promoter strength, it 
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was kept for further analysis, in order to have a broader look at the parameter space of the 
system. 
In pR5 expression of GFP is under the control of both OmpR-P and TetR. When the 
strength of the synthetic promoter is within a certain region, TetR levels should be such 
that GFP expression is completely repressed by TetR in the absence of a signal, but upon 
a positive signal OmpR-P levels should increase, out-compete TetR and activate GFP 
expression.  
Apart from this system of regulation two more systems were constructed to compare 
the effectiveness of different circuitry. 
One of these systems is based on post-translational control: a 200 bp stretch of DNA 
corresponding to the anti-sense strand of the beginning of GFP was cloned by KpnI-ClaI 
in pR5 and pR5C, replacing the SD and tetR gene and resulting in pR6 and pR6C 
respectively. 
The other one is based on the gene toggle switch: a temperature sensitive form of CI 
(CIts; Gardner et al, 2000) was cloned with a weak SD sequence as an operon fusion to 
GFP by XbaI-XbaI into pR5 and pR5C, resulting in pR7 and pR7C. CIts has the 
following mutations in respect to CI: A67T, E118K and S125G. The toggle switch should 
give the most robust and effective regulation provided that the parameters of the system 
like promoters’ strength, translation efficiency, protein degradation etc, are such that 
allow the system to be bistable (Gardner et al, 2000). The stop codon of CIts was chosen 
to be tga so that an overlapping dam methylation site with the XbaI site is created, 
allowing discrimination between the two XbaI sites in plasmid preparations from dam- 
strains, since XbaI is sensitive to methylation (fig.III-13). 
 
 
 
Fig.III-13. The CIts fragment in pR7. The overlapping dam methylation site that renders the last XbaI site 
sensitive is shown in blue. 
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Testing the reporter systems 
 
All the experiments for testing the constructs were done at 37ºC, although it is not the 
optimal temperature for CIts, because at that temperature (30-32ºC) the cells needed more 
than 14 h to grow in labelling medium. 
 
 
 
Fig.III-14. Western blot with anti-GFP of cells AT142 carrying Taz and the different reporter systems 
exposed to 5 mM L-Asp for 1h in the presence or absence of aTc. Cells were grown in labelling medium 
with the exception of the A6 in the first two lanes which were grown in LB in order to see if there is a 
difference in GFP expression in rich media. Samples A1-A4 carry constructs pR1-pR4 and A5C-A7C have 
the respective reporters with the mutant synthetic promoter 
 
As shown in fig.III-14 the promoter with the T->C mutation is probably too weak to 
have any effect in any of the systems tested whereas the opposite holds for the originally 
designed promoter. Adding increasing amounts of aTc does not seem to affect expression 
of GFP (data not shown). This suggests that either the level of TetR produced is too high 
and repression cannot be relieved even at 100 µg/ml aTc or there is a secondary effect, 
like DNA supercoiling, which prohibits transcription from pompC. The possibility that in 
this case pompC has been mutated by the cells to lose completely function, instead of the 
synthetic promoter can be ruled-out, since cells with pR6 produce low levels of GFP 
when grown in rich media. 
In order to test the amount of TetR produced from every construct samples were 
analysed as before, using a mixture of two monoclonal anti-TetR antibodies. As a control 
of the level of expression an o/n culture of XL1-Blue cells grown in LB with tetracycline 
was used, because XL1-Blue carry the Tn10 in the F episome. As shown in fig.III-15(A) 
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constructs with the mutant promoter expressed TetR at much higher level than the Tn10 
in XL1-Blue, whereas the normal synthetic promoter is completely silent. 
 
 
 
Fig.III-15.  (A) Western blot using a mixture of two monoclonal anti-TetR antibodies of AT142 cells 
carrying Taz and the respective reporter in the presence or absence of 5mM L-asp. PR6 was used as a 
negative control, since it does not carry the tetR gene and XL1-Blue cells, grown in LB+tetracycline, as a 
positive control because they have the Tn10. (B) Western blot under the same conditions as in (A), for cells 
carrying pR5C and DH5αZ1 cells which express enough TetR to regulate Ptet promoters. The lower band 
corresponds to the TetR from Tn10 and the upper to TetR which is integrated in the chromosome. 
 
Although the level of TetR produced by the mutant promoter is higher than in the 
control, the failure to control expression from pompC suggests that either competition for 
binding to C1 is not enough in the presence of C2 and C3 or that the level of TetR is still 
too low to achieve competition. The latter case was tested by comparing the level of TetR 
produced by pR5C and strain DH5αZ1 which carries both Tn10 and a chromosome-
integrated TetR and has been shown to regulate promoters carrying two tet operators. As 
shown in fig. III-15(B) the amount of TetR produced in DH5αZ1 is more than double 
than that produced by pR5C. The two bands in the blot correspond to the TetR from Tn10 
and the chromosome-integrated TetR which has 18 additional amino acids at the N-
terminus. Therefore it seems possible that the amount of TetR produced by the mutant 
promoter is insufficient to repress expression from pompC, which has only one mutant tet 
operator, despite the fact that the affinity of TetR for its operator is much higher than the 
affinity of OmpR-P for C1. 
The fact that in the constructs with the designed synthetic promoter there was 
expression neither of GFP nor of TetR raised the question of the integrity of the 
construct. The promoters and the genes were sequenced again and there was no mutation, 
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 insertion or deletion. However, by doing diagnostic PCR, a DNA fragment of 
approximately 1.2kb was mapped after the gfp gene. This DNA fragment is absent in the 
parental plasmid (pR4) and also in the constructs with the mutated promoter and 
therefore it appears to be a good candidate for silencing both promoters. Its origin is not 
known, since construction of pR5 from pR4 does not involve that region of the vector. 
Partial sequencing of this fragment reveals that it is inserted at the end of the gfp gene 
and that it corresponds to a fragment of the transposase gene from Tn10, containing only 
part of the enzyme and several stop codons, encoded on the same strand as gfp. The way 
in which this fragment could silence the two promoters is unclear, but it could account for 
the fact that the DNA sequence was tolerated by the cells and not mutated like in the 
other cases: if a strong synthetic promoter is unfavourable for the cells, then indirect 
silencing, instead of mutating the promoter, could give a survival advantage to the cells 
while keeping the integrity of the DNA sequence of the construct. 
The latter is further demonstrated by the following experiment: since the construct 
with the insertion had the correct DNA sequence, the fragment containing the spacer, the 
synthetic promoter, the tetR gene and rrnB terminator was cut-out with Sac I and Cla I 
and re-inserted into pR4, yielding pR5X. In all of the colonies sequenced the vector had 
undergone  recombination, in a different way for each colony:-using primers designed  to 
sequence the construct, yielded instead the sequence of different regions of the plasmid 
which are not in the vicinity of the cloned genes, e.g. in one colony the sequence of part 
of the antibiotic resistance gene was obtained instead of tetR. 
 
 
 
Fig.III-16. Western blots using either anti-TetR or anti-GFP to determine the level of each protein in 
two different colonies of pR5X. Lane 1 DH5αΖ1, lanes 2,5 SA with no amino acid and 6,7 with L-asp and 
L-leu, lanes 8,9 pR5X, Taz carrying cells colony #3  with or without L-asp and lanes 10, 11 colony #4. 
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Two of the clones were transformed into AT142/pR2 cells and were tested by SDS-
PAGE and western blotting for TetR and GFP expression in the presence or absence of 
L-aspartate (figIII-16). Only one of the clones expressed GFP, but none of the clones 
expressed TetR, although the presence of the tetr gene was verified by PCR. 
 
 
 
 
 
 
Design of receptors with mutated ligand binding domain 
 
Analysis of the Crystal structures used for computer Design 
 
The success of protein design depends on the quality of the template structure that is 
being used. In this case, the best crystal structure is that of the periplasmic domain of Tar 
from Salmonella typhimurium in complex with one aspartate molecule (pdb code 2LIG). 
In table III-1 the available apo structures of Tar and the aspartate bound form from 
S.typhi (TarS) and E.coli (TarE) are listed. Structures of the apo form had a monomer as 
the crystal lattice unit, due to the dimer’s symmetry. Thus the structure of the dimer was 
re-constructed with the programme SwissPdbViewer using the instructions given in each 
pdb file. The RMSD of the structures with respect to the apo-TarS (1LIH) was calculated 
either for the whole structure or excluding the last helix of the periplasmic domain, which 
has been proposed to move upon aspartate binding, according to the piston model 
(Ottemann et al, 1999). 1LIH was chosen as a reference because it is the only apo 
structure with an available aspartate bound structure of high resolution. In fact the latter 
structure, with only one site occupied by aspartate, should be the most representative 
because in E.coli, in contrast to Salmonella, negative co-operativity allows binding of 
only one aspartate molecule per receptor dimer, within the physiological range of 
aspartate concentration (Biemann and Koshland, 1994). 
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Table III-1. Available structures for apo Tar of S.typhi and E.coli and the highest resolution ligand bound 
structure of Tar of S.typhi (Björkman et al, 2001) 
 
Pdb 
code 
Description ligands Resolution 
(Å) 
RMSa 
(Å) 
RMSb 
(Å) 
1LIH Salmonella, cross-linked 
with disulphide bonds (xx, 
yy) 
phenanthroline 2.2 - - 
2LIG Salmonella, cross-linked 
with disulphide bonds (xx) 
L-aspartate 
Phenanthroline 
1 sulphate 
2.0 2.76 2.60 
1WAS Salmonella, wild-type (zz) - 2.7 2.65 2.66 
1VLS Salmonella, wild-type 
(ww) 
- 1.85 2.54 2.57 
2ASR E.coli, wild-type (qq) 2 sulphates 2.3 2.11 2.26 
 
a RMS deviation of the backbone atomes of the whole periplasmic domain, with 1LIH as 
a reference. 
b RMS deviation of the backbone atomes of the periplasmic domain without the most C-
terminal helix, with 1LIH as a reference 
 
As shown in table III-1 the RMS deviation is approximately the same for the 
aspartate-bound structure and the various apo structures, even when the “in theory 
moving” helix is excluded. Thus it appears that the “movement” assigned to the last helix 
upon aspartate binding, based on structures 1LIH and 2LIG, is actually within the 
structure refinement error and probably reflects a difference in crystallisation conditions 
and packing rather than a conformational change with biological significance. Of course 
this raises the questions which is the true apo conformation of the receptor and which is 
the actual mechanism of signal transduction.  
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However it should be noted that since the available structures corresponds only to the 
periplasmic domain, it could be possible that the actual structure in the wild-type Tar 
and/or the chimera is altered because of constraints rising from the transmembrane and 
cytoplasmic regions. 
This poses a problem for a computer design exercise because we do not know the 
structure of at least one relevant state and therefore when making mutations we could 
create unwanted compensatory effects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Testing the prediction capability of the design algorithm 
 
Before trying to change the specificity of the receptor, it is necessary to test how well 
the computer design can predict the effect of mutations on aspartate binding in wild-type 
Tar. Perla algorithm (Angrand et al, 2001)was used to create the structures of the 
complex aspartate-Tar for different mutants for whom the Kd has been experimentally 
measured. The structures generated were subjected to two cycles of energy minimization 
using the programme SwissPdbViewer 3.7 and the energy of the complex was calculated 
using the Fold-X algorithm (Guerois and Serrano, 2000; Guerois et al, 2002 ). 
As shown in table III-2. The effect of most mutations can be predicted reasonably 
well. 
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Table III-2. Experimental Kd and swarming rates, in mm/h when the cells are exposed to 0.1 mM L-
Asp from (Björkman et al, 2001) and predicted Kd for mutations of the residues interacting with the ligand. 
 
mutation Kd (M-1) swarming Predicted Kd (M-1) 
WT 0.000003 0.27 0.000001 
R64A 0.047 0.04 0.001 
R64C >0.100 - 0.002 
R64D 0.021 0.02 2.24 
R64K 0.030 0.03 0.0001 
R64S 0.040 0.04 0.0009 
S68C ~0.000002 - 0.000003 
S68G ~0.000002 - 0.000003 
S68H ~0.000002 - 0.000002 
S68I ~0.000002 - 0.000003 
R69A 0.008 -0.02 0.005 
R69C 0.002 - 0.004 
R69H 0.005 - 0.0001 
R69K 0.0002 0.34 0.0002 
R69D - 0.025 25 
R69S - 0 0.008 
R69P 0.0039 - - 
R69M - - 0.0002 
R73C 0.007 0.06 0.0015 
R73K 0.0004 0.18 0.00006 
R73S 0.007 0.04 0.0015 
R73D - 0 0.04 
R73W 0.003 - ** 
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The possibility of other amino acids binding at the same pocket was tested by 
calculating the Kd values for the respective complex. Amino acids that have reasonable 
predicted Kd values (that is without large Van der Waals clashes) are shown in table III-3. 
 
Table III-3. Predicted Kd for different amino acids as ligands in the place of aspartate. Values only for 
amino acids which did not have large Van der Waals clashes are shown. 
 
Amino Acid Kd (M-1) Amino Acid Kd (M-1) 
D 0.000001 S 0.001633 
E 0.000007 T >0.100 
Q 0.000831 V 0.001689 
A 0.011777 I 0.004204 
G >0.100 L 0.129576 
C 0.104035   
 
As expected aspartate and glutamate have the lowest Kd values and the rest have at 
least 10-fold higher Kd values than glutamate, with glutamine being the next amino 
amino acid with low Kd. Experimentally it has been shown that glutamate is sensed by 
Tar with lower affinity than aspartate, although the experimental difference was 
approximately 1000-fold (Utsumi et al, 1989; Baumgartner et al, 1994) instead of the 
predicted 10-fold. Glutamine has been shown to have a Kd >10mM and appears not to be 
a chemoattractant with the classic chemotaxis assays (Clarke and. Koshland, 1979). The 
value of the Kd is at least 1 order of magnitude higher than glutamate which is in 
agreement with the prediction 
Thus with all the caveats associated to the fact that we do not know the structure of 
one of the states, the design algorithms seem to perform well when confronted to simple 
cases. 
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Designing new specificity 
 
Before engineering a receptor with completely different specificity from the parent 
receptor, it is necessary to test how feasible it is to change the specificity towards stimuli 
which are close from a structural point of view, to the original one, i.e. amino acids. This 
means that the residues which contribute to binding of the ligand backbone remained 
unaltered and only the residues contributing to side-chain binding were mutated in silico. 
The network of the native interactions in the wild-type complex is shown in fig.III-17. 
 
As candidates for new ligands four amino acids were chosen: 
? 
? 
? 
Leucine, because its side-chain has a similar structure to aspartate but it is a 
hydrophobic residue. 
Glutamine, because it is close in structure and nature to glutamate which is also a 
ligand for Tar. 
Serine and threonine, because the serine receptor, Tsr, has a binding pocket which 
differs only in a few amino acids, mainly 2, from that of Tar. Thus in this case we 
just computationally changed those residues, plus a few ones in the case of Thr. 
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Fig.III-17. (A) Crystal structure of the periplasmic domain of Tar from Salmonella tuphimurium with a 
single L-aspartate molecule (magenta). (B) The hydrogen bond network for binding of aspartate to the 
receptor (C) The ligand binding pocket. Residues which were mutated are shown in green. 
 
 
 
The name given to each receptor was representative of the amino acid it was designed 
to bind, i.e. TaL for leucine, TaQ for glutamine, TaS and TaT for serine and threonine 
respectively. Structures of the putative complexes were generated with Perla and treated 
the same way as the Tar mutants. For TaS and TaT the mutations chosen were such that 
they would recreate the binding site of Tsr, with the difference that there were extra 
mutations for TaT, in order to have space for accommodating the methyl group. For TaL 
and TaQ residues shown in table were randomly mutated and only the mutations with the 
best energy were chosen for experimental test. 
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Table III-4. Residues in the binding pocket for the designed receptors. Mutations are shown in red. 
 
Residue Taz TaL TaQ TaS TaT 
67 L L I L L 
68 S I S N N 
149 Y F N F F 
69B R L L R K 
72B V M A V V 
73B R M R R M 
82B Q A Q Q Q 
89B L W W L L 
 
 
Table III-5. Predicted Dissociation constants (M-1) for D and the respective ligand for each receptor 
 
 D L S T Q 
WT 0.000001 0.129576 0.001633 0.689670 0.000831
TaL 0.395005 0.001311 - - - 
TaS 0.000013 - 0.001633 - - 
TaT 0.001605 - - 0.032994 - 
TaQ 0.006860 - - - 5.2 
 
 As shown in table III-5, there is a shift in the specificity for TaL, although the 
absolute value of the Kd for Leu is not very satisfying. Surprisingly TaS (and TaT) is 
predicted to have higher affinity for aspartate than serine despite the fact that the 
introduced mutations were chosen specifically to re-constitute the binding site of Tsr. In 
the design of TaQ there was a design error, but the mutations from the prediction were 
anyway experimentally tested, because in the predicted structure the substituted residues 
take up almost the whole binding pocket which could lead to an interesting behaviour.  
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Construction of receptors with mutated ligand binding domain 
 
In order to construct the receptors which carry several mutations in the ligand binding 
domain, two restriction sites were introduced within the Tar coding sequence to facilitate 
cloning. A Pst I site was introduced at position 281, where the numbering corresponds to 
the DNA sequence of the chimera, by changing with PCR-ATW the caa codon to cag, 
causing no change in the protein sequence. Taz2 cloned in pBluescript KS (pBTaz2) was 
used as a template. Subsequently, a Nco I site was similarly introduced at position 578, 
restoring at the same time the A160V mutation. The resulting construct was named 
pCOR. The fragments with the mutations were constructed using overlapping oligos as 
described in the Materials and Methods section and cloned in pCOR, substituting the 
wild-type ligand binding domain. The constructs were sequenced and correct clones were 
sub-cloned into pCL1920 using Hind III and BamH I. 
Single point mutants were generated by PCR-ATW using pBTaz2 as a template and 
then sub-cloned into pCL1920.  
Plasmids pCL1920 carrying the different receptors were named after the receptor that 
they are carrying, e.g. plasmid pCL1920 with TaL was named pTaL. These constructs 
were transformed into AT142 cells harbouring pR2 by using the TSS method. 
 
 
 
 
 
 
Testing the mutant receptors 
 
TaL and TaQ receptors were tested by exposing AT142 with pR2 carrying the 
respective constructs to either L-Leu, L-Asp, L-Gln or no amino acid. As controls cells 
with Taz were used, but also AT142 cells with pR2 but no receptor, in order to check the 
background level of expression in the absence of an EnvZ catalytic domain.  
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Fig.III-18. Western blot using, anti-GFP, of AT142 cells carrying pR2 (A2) or pR2 and a receptor (Taz, 
TaL or TaQ). Cells were exposed for 1h to either no stimulus (lanes 1), 5 mM L-Asp (lanes 2), 5 mM L-
Leu (lanes 3) or 5 mM L-Gln (lanes 4). 
 
As shown in fig.III-18 the cells without a receptor do not have detectable GFP levels 
and therefore in this strain and under the experimental conditions the presence of a 
functional EnvZ-C is required for GFP expression. TaQ is locked in the active state and 
cannot respond to any of the signals tested. The fact that the locked-on TaQ results in the 
same levels of GFP expression for all the amino acid tested, shows that under the 
experimental conditions, there is no significant effect on OmpR levels, through possible 
changes in its transcription by CRP. L-Gln does not have an effect on either Taz or TaL, 
but surprisingly L-Leu seems to have an inhibitory effect on both TaZ and TaL. 
When TaS and TaT were tested for L-Ser, L-Asp, L-Thr and L-Cys only L-Asp 
activated TaS as computationally expected (fig.III-19), whereas the other aa had no effect 
on GFP expression and TaT was locked-off (data not shown). 
 
 
 
Fig.III-19. Western blot using, anti-GFP, of AT142 cells carrying pR2 and TaS, exposed to 5 mM of L-
amino acids for 1h 
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TaL was re-designed, aiming to achieve activation by L-Leu. The new receptor was 
named TaLM because it had only the mutations R69M and R73M. The predicted 
dissociation constants for aspartate and leucine were ~150 mM and 573 µM respectively. 
Surprisingly this mutant was locked-off and not partially responsive like TaL. In order to 
check if one of the mutations in TaLM was responsible for the complete loss-of-function 
the single mutants R69M, R73M were constructed. Since TaL has the mutation R69L, the 
respective single mutant was also constructed. 
 
 
 
Fig.III-20. GFP levels for the different receptor mutants and TaL, exposed to Asp, Leu and Met. The 
data of each series, which correspond to the average of three experiments, are normalized to the value of 
the respective control 
 
As shown in fig.III-20 all single-point mutants have a non-detectable basal level but 
respond to L-Asp. Therefore the basal level observed in the case of TaL should be the 
result of partial activity recovery by one or the combination of the rest of the mutations 
introduced. 
In conclusion, the designed mutants were not able to respond to the target amino acids. 
In the case of Leu, an inhibitory effect was seen which later was also seen for the WT 
receptor (see following chapters) and could mask any activation. Replacement only of the  
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conserved Arg73 locked the receptor in an off conformation which could be explained by 
the hydrophobic residues been more favourable in the inactive conformation than when 
bound to Leu. For Ser although the mutations introduced were the ones that make the Tar 
binding pocket different from that of Tsr, was not abolished. This is interesting because it 
is the expected behaviour from the computer prediction (this will be discussed later on in 
the following chapters). Finally, the receptor designed to bind Gln did not respond to it, 
as expected when we realized our mistake. However, this mutant proved to be very 
interesting for understanding the chimera as explained later. 
It should be noted that the effect of the single point mutations in the ligand binding 
domain of Taz cannot give any answer to the question if leucine binds the same way as 
aspartate, since it has already been shown that different mutations in the binding pocket 
can have two very different effects (Yang et al, 1993): the R64C substitution renders Taz 
constitutively active, whereas the R69H or R73Q substitutions eliminate the sensing 
properties of Taz without changing its baseline kinase and phosphatase activities. 
 
 
 
 
 
Responsiveness of Taz to L-amino acids 
 
These results and especially the fact that L-leucine seems to inhibit the wild-type Taz 
suggested that it is necessary to examine carefully the response of the Taz system to all 
natural aa before trying to modify the receptor’s specificity. To do so, the system was 
exposed to 5 mM of each amino acid for 1h at 37˚C, as described in the Materials and 
Methods section. As shown in fig.III-21, L-Asp and L-Glu clearly activate the system and 
L-Pro can elicit a stimulatory effect only at very high concentration (20 mM). Using such 
a concentration for L-Pro was based on earlier chemotaxis studies which suggested that 
L-Pro could elicit a moderate attractant response only at high concentrations and maybe 
through its metabolism (Mesibov and Adler, 1972). 
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Fig.III-21. Response of SA cells to exposure for 1h at 37°C to 5 mM of L-amino acid and also to 20 
mM L-Pro (P20). Activating amino acids are shown in green and inhibitory in red. The values represent the 
average of three experiments and were normalized to the value of the control (no stimulus). 
 
Although some amino acids like L-Ala seem to have a very small stimulatory effect, it 
is not comparable to that of L-Asp and L-Glu and is within the noise. Surprisingly L-Leu, 
L-Met, L-Ser and L-Val had a clear inhibitory effect whereas in the case of L-His there is 
inhibition but not as strong as for the other aa. The 40-50% GFP level measured for these 
samples at a first glance does not seem very important. However if one considers the 40 
min half-life of GFP(LVA), cell growth and the small time-frame of the exposure to the 
signal (1h) it appears that this level of GFP corresponds to what would be expected if 
GFP production ceased instantaneously upon addition of the signal. This is more obvious 
with the following experiment: cells are allowed to grow without L-Leu and when they 
enter into the logarithmic phase of growth they are divided into two flasks. In one of 
them the cells continue growing without any signal and in the other they continue 
growing in the presence of saturating L-Leu (5 mM). Samples from both flasks were 
taken every 30 min. If GFP production ceased completely then the amount of GFP that 
should be detected at a given time point should be given by the exponential decay of 
GFP, with t1/2= 40 min, corrected for cell growth – i.e for time-point i where the cells 
have reached an absorbance of OD600i the % of GFP detected should be given by the 
equation: 
 
iGFP(%) = 600
i −1OD
600
iOD
100 e
− t 1 .5 ln 2  
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Comparing the theoretical values to the experimental ones (fig.III-22) it is obvious that 
L-Leu shuts down completely production of GFP.  
 
 
 
Fig.III-22. Growth curves (X and ∆) and GFP levels (?and?) in SA cells grown at 37°C in the 
absence of a stimulus or at constant saturating L-Leu concentration, once they entered into exponential 
phase, respectively. The theoretical decrease of GFP, in the case of complete cessation of GFP production, 
correcting for cell growth is shown in red (♦). 
 
However, different questions are raised by this experiment: since the wild-type EnvZ-
OmpR system is activated after mid-logarithmic phase by an unknown mechanism 
(Martinez-Flores et al, 1999) why does the Taz-OmpR system remains regulated in the 
logarithmic phase and could the chimeric system respond independently of the state of 
cell growth?  
 
 
Dependence of the system’s responsiveness on cell growth 
 
These questions were addressed by following the GFP levels in cells that were 
growing in the absence of signal and by exposing cells that are at different points of the 
growth curve for 1h to L-Asp and L-Leu. 
In the absence of a signal the GFP levels decrease throughout the whole growth curve, 
even at early stationary phase and increase only after o/n growth (fig.III-23). 
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Fig.III-23. Growth curve of SA cells in labelling medium the absence of any stimulus. The OD600 
values (x) are plotted against the secondary Y axis. The levels of GFP, normalized to the first data point, 
are shown with (♦), plotted against the primary Y axis. 
 
 When cells from the o/n cultures are exposed to either L-Leu or L-Asp they do not 
respond (data not shown) which means that activation of the system by products of cell 
lysis is improbable. Thus the system seems to be activated only at very late stationary 
phase but probably through a different mechanism. 
Following the responsiveness of the system through-out the logarithmic phase it seems 
that the system retains its ability to be regulated by the amino acids. Activation by 5 mM 
of L-Asp seems to be increasing with time when each data point is normalised to the 
respective point of non-induced cells (figIII-24(A)). However this is an artefact produced 
by the fact that the level of GFP in the non-induced cells decays with time. When the data 
points are normalised to the initial value of GFP for the non-induced cells it is clear that 
the amount of GFP is approximately the same for all cases which means that 5 mM of 
Asp saturate the system and this happens independently of the state of cell growth. 
Similarly responsiveness to L-Leucine seems to be constant (figIII-24(B)), because L-
Leu stops completely GFP expression and thus the difference between the induced and 
non-induced cells at any time point remains the same. However since the basal GFP level 
decreases with time the sensitivity of the measurement will also decrease at points later in 
the growth curve. 
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Fig.III-24. Responsiveness to L-Asp and L-Leu at different points of the growth curve. Cells were grown 
in labelling medium and starting at t0 = 4 h, which corresponds to the beginning of the exponential phase, 
aliquots were taken and exposed to 5 mM of each amino acid for 1h. In both plots the GFP levels in non-
exposed cells are shown with (♦), normalized to the first data point. (A) Responsiveness to L-Asp; in (?) 
values are normalized to that of control cells at t0 and in (Ο) values are normalized to the corresponding 
value of the control cells at the specific time-point (B) Responsiveness to L-Leu; in (σ) values are 
normalized to that of control cells for t0 and in (∆) values are normalized to the corresponding value of the 
control cells at the specific time-point. 
 
 
These mean that although the system responds equally well through-out the whole 
logarithmic and early stationary phase, the sensitivity of the method is best at early points 
of growth for studying repression and later points for studying activation. 
 
 
The inhibitory effect of Leu is applied on the first level of the pathway, the 
receptor 
 
As already mentioned, since the cloned pompC carries 4 sites for Lrp, the observed 
effect of Leu inhibition could be indirect through this protein. To test this hypothesis cells 
were exposed to different amounts of L-Leu, since it is the only amino acid from the ones 
for which e have observed an inhibitory effect that is reported to bind to Lrp, in the 
presence/absence of saturating L-Asp (5mM). At the range of concentrations tested L-
Leu had a dominant effect over L-Asp (fig.III-25). The same was true when L-Met was 
used instead of L-Leu. 
Results 68
 
 
 
Fig.III-25. (A) Competition between saturating L-Asp (5 mM) and different concentrations of L-Leu 
(blue bars) or L-Met (yellow bars). (B) Competition between L-Asp and L-Leu at concentrations of Leu 
below 1 mM (?). Cells treated only with L-Leu.(♦) are shown as a control. In all cases data are normalized 
to the value for non stimulated cells. 
 
This together with the fact that the locked-on TaQ receptor shows no change of GFP 
levels in the presence of  L-Leu show that an active receptor can produce enough OmpR-
P to out-compete any putative effect of Lrp and therefore L-Leu, as well as the other 
amino acids, should be acting on the receptor. It should be noted that the conclusion 
drawn with the locked-on TaQ is valid only provided that the level of OmpR-P produced 
by activated Taz and locked-on TaQ is the within the same range than in the wt Taz. In 
order to check if this inhibition was due to an interaction of the amino acids with EnvZ-
C, BL21(DE3) cells carrying pR2 were subjected to osmotic shock in the presence and 
absence of 5 mM L-Leu in medium A. The response was the same regardless of the 
presence of L-Leu (figIII-26), indicating that L-Leu and the other inhibitory amino acids 
are probably interacting with the Tar part of the chimera. 
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Fig.III-26. Osmotic response in the context of L-Leu. BL21(DE3) cells carrying pR2 were grown in 
medium A with or without 0.3M NaCl in the presence (yellow bars) or absence (blue bars) of 5 mM L-Leu. 
 
 
Stereo-specificity in sensing the amino acids which elicit a response  
 
Since the majority of the inhibiting amino acids have a hydrophobic side-chain, the 
possibility of non-specific hydrophobic interactions with the receptor had to be 
considered. This question was addressed by exposing cells to either D- or L- amino acids. 
As shown in fig.III-27 the inhibitory effect is stereo-specific for the L- form of the 
hydrophobic amino acids, whereas it seems not to be stereo-specific for polar ones 
regardless if they are activating (DL-Asp) or repressing (DL-Ser) the system. It should be 
noted that L- and D-His are also discriminated (data not shown). 
 
 
 
Fig.III-27. Western blot, using anti-GFP, for cells exposed to 5 mM of L- and D- amino acids for 1h. 
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Apparent affinities for L-Asp, L-Leu and L-Met 
 
The competition experiments had already shown that the system has a greater apparent 
affinity for L-Leu and L-Met than for L-Asp. In order to have a more representative 
image of the apparent affinities cells were exposed to different concentrations of the 
respective amino acid, the data were fitted to a sigmoidal curve (fig.III-28) and the IC50 
was calculated.   
 
 
 
Fig.III-28. Dose response curves for L-Asp (Ο), L-Leu (∆) and L-Met (?). 
 
 
The equation used for fitting the data was equation 1 for L-Leu and L-Met and 
equation 2 for L-Asp. 
 
y= min+ max− min
1+ −(logIC50−log C )10      (1)               y= min+
max− min
1+ log IC50−log C10     (2) 
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For each amino acid the experiment was repeated three times and the final apparent Kd 
represents the average of the IC50 values, calculated from each experiment.  
The apparent Kd for L-Leu is 39.6 ± 27.9 µM, for L-Met 127 ± 82 µM  and for Asp 
266 ± 103 µM. Although the values have a substantial error, they follow the trend of the 
competition experiments: L-Leu and L-Met can out-compete in descending order L-Asp. 
 
 
Construction and testing of Tsr-Tar-EnvZ chimeras 
 
The puzzling behaviour of TaS raised the question whether the two mutations 
introduced in the Tar ligand binding domain were enough to re-construct the Tsr binding 
domain. Taking a closer look at the crystal structure of the aspartate occupied binding site 
it was considered that positions 72 (Val in Tar, Ile in Tsr) and 65 (Ile in Tar, Asn in Tsr) - 
although not interacting directly with the ligand could influence its binding (figIII-29).  
 
 
 
Fig.III-29. The ligand binding pockets of Tar and Tsr. (A) sequence alignment of the periplasmic domains. 
Triangles indicate the residues involved in ligand-binding for Tar. In red rectangles are marked the residues 
which were initially considered for TaS and in blue rectangles the two extra residues close to the binding 
pocket which are different (B) Crystal structure of Tar-L-Asp complex (2LIG). The residues which are 
different in Tsr are shown in cyan. 
 
For example although residue 65 is not directly involved in binding, it can affect the 
number of  water molecules present in the pocket, which take part in the hydrogen-bond 
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network that contributes to the binding of the amino acid.  However, when the mutations 
were modelled and the binding of aspartate and serine was calculated, aspartate was 
found again to be recognised with higher affinity than serine, with respective binding 
energies –7.38 kcal/mole and –2.14 kcal/mole. The mutant receptor, TSNI, showed a 
peculiar behaviour which is described below, together with that of Tsr chimeras. 
The chimera between Tsr and EnvZ, Tsz, was constructed, in order to see if it would 
be activated by L-Ser like Taz is activated by L-Asp. TsZ was constructed by amplifying 
the respective part of Tar with HindIII and NdeI sites at the ends and replacing the 
respective part of Tar in the Taz construct. However cells with Tsz showed a very low 
basal level of GFP and no responsivess to any amino acid as will be shown later. 
This was a surprising result taking into account the high degree of homology between 
Tsr and Tar.  To solve the problem  Tar-Tsr-EnvZ chimeras were constructed, hoping that 
the signal transduction ability of the Tar-EnvZ fusion could be combined with the sensing 
properties of  Tsr. As shown in fig.III-30 two different triple chimeras were constructed:  
 
 
 
Fig.III-30. Schematic drawing of different chimeras combining parts of Tar (grey), Tsr (cyan) and 
EnvZ (red). In TSNI the mutations that were introduced in order to reconstitute the Tsr binding domain are 
depicted as cyan dots. 
 
TsaZ which has the N-terminus, first transmembrane part (TM1) and ligand binding 
domain of Tsr and is fused to Taz at position 179, where the numbering corresponds 
to wild-type Tar. Construction of Tsaz was based on the observation that the TM2 of 
? 
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Tar and Tsr are interchangeable (Tatsuno et al, 1994). Tsaz was constructed as 
follows The N-terminus of Tsr up to the second EcoR V site of the coding sequence 
(535) was amplified by PCR, since this site is at the same position as the unique EcoR 
V site in Tar. This fragment was fused by PCR to a fragment corresponding to the 
coding sequence of Tar which is flanked by the unique EcoR V site for Tar, and the 
NdeI site. The Tsr-Tar fragment was subsequently used to replace the Tar moiety of 
Taz. 
? TasZ which has the ligand binding domain of Tsr fused at positions 61 and of 162 
Taz, where the numbering corresponds to the wild-type Tar. Construction of Tasz was 
done by taking advantage the Taz construct which has the ligand binding domain in 
the form of a PstI-NcoI cassette. 
 
 
Checking the suitability of the genetic background for the expression of the new 
receptors 
 
It should be noted that as aforementioned the strain used for these experiments 
(AT142) has the flhD5301 mutation and therefore transcriptional units like the tar-tap 
operon, which are controlled by the FlhD/FlhC activator should be silent (Liu and 
Matsumara, 1994). Although it has been assumed that all chemoreceptors are under the 
control of this transcription factor it has been clearly demonstrated for Tar, Tap (Liu and 
Matsumara, 1994) and Aer (Pruss et al, 2003) but not for Trg and Tsr. Therefore it seems 
possible that in this genetic background Tsr expression is not abolished and formation of 
hetero-dimers prevents the formation of an active chimera. The study of the chimera 
between Trg-Envz, Trz, carried by Baumgartner et al was done in a similar genetic 
background without however any similar complications. This could be due to the fact that 
the expression level of the chimera was higher than in this study but also because Trg is a 
low abundance receptor whereas Tsr is the most abundant of the chemoreceptors, being at 
least at 20-fold higher levels than Trg. 
Therefore before studying the chimeras mentioned above it is necessary to clarify 
whether Tsr is being expressed in the cells. This possibility was tested by growing 
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overnight cells which contain no, some or all of the receptors and strain AT142 and 
comparing their profile in western-blots with antibody against residues 290-470 of Tsr 
which are conserved in the MCPs. The control cells were: 
RP437 which has all the MCPs. This strain was grown in Trp broth, which is the 
medium commonly used for chemotaxis assays, in order to ensure expression of the 
MCPs and avoid effects from the metabolism. All the other strains were also grown 
in Trp broth in order to have comparable results, apart from AT142 which was also 
grown in labelling medium to check if its profile is different in the medium used for 
the chimera assays. 
? 
? 
? 
UU1250 which has none of the five MCPs. 
UU1250 carrying plasmid pLC113. These cells express Tar at levels which can elicit 
taxis to aspartate only when they are induced with 0.7 µM sodium salicylate, as 
previously described (Ames et al, 2002). They were grown both in the absence of 
inducer, in order to check the basal level of expression from the promoter and in the 
presence of inducer, to check the level of receptor that is required for a response. 
 
 
 
Fig.III-31. Western blot, using polyclonal antibody against the 290-470 region of the MCPs. Cells were 
grown o/n at 37°C in TB apart from AT142 which were grown both in TB and labelling medium. Lane 1 
corresponds to UU1250, lanes 2 and 3 to UU1250/pLC113 without or with induction with 0.7µM sodium 
salicylate, lane 4 to RP437 (wt) and lanes 5 and 6 to AT142 grown either in TB or labelling medium. 
 
As shown in fig.III-31 the basal level of the inducible promoter is quite high and the 
amount of receptor induced from the plasmid is similar to the sum of all the receptors in 
the wt. The receptor-less strain shows a very faint band which seems not to be specific. 
The profile of AT142 in either medium is similar to that of the receptor-less strain. 
Therefore it is safe to assume that the flhD5301 mutation is sufficient to limit expression 
Results 75
of the MCPs and even if Tsr is expressed at all, its level would be too low and probably 
insufficient to sequester the chimeric monomers. 
 
 
Behaviour towards amino acid of the new receptors 
 
Once ensured that wild-type Tsr is not expressed in our cell lines the behaviour of all 
constructs was analyzed, when exposed to L-Ser and L-Asp (figure III-32). 
 
 
 
Fig.III-32. (A) Western blot of cells with pR2 and either Tsz, Tsar or Tasz, exposed to 5 mM of L-Asp 
and L-Ser.(B) Responsiveness of TSNI (blue bars) and Tasz (yellow bars) to L-Asp and the inhibiting for 
Taz amino acids. 
 
The chimeras Tsz and Tsaz are locked in a non-responsive very low basal level state, 
but the re-designed TSNI mutant (see first paragraph of this section) and the chimera 
Tasz show a new pattern: The basal level of the receptor seems to be saturating like to 
that for activation of Taz by Asp. L-Asp doesn’t seem to have any effect, but L-Ser 
inhibits both receptors.  
Looking into the effect of the rest of the inhibitory aa for Taz (fig.III-32B), they seem 
to have an inhibitory effect on both TSNI and TasZ which is however more profound for 
TSNI. Therefore just by mutating 4 residues in the ligand-binding domain of Taz to the 
respective ones in Tsr, it is possible to imitate the behaviour of the whole ligand binding 
domain of Tsr.   
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Chemotaxis studies 
 
Leucine taxis 
 
Assuming that the conformational changes in Tar and Taz are co-related, then since 
aspartate, which is an attractant for Tar activates Taz and leucine inhibits Taz it is 
possible that leucine might be sensed as a repellent by Tar. Leucine has been described in 
very early chemotaxis studies as a repellent and the response has been assigned to the 
serine receptor, Tsr (Reader et al, 1979 ). However, more recent studies with capillary 
(Mao et al, 2003) and tethered cell assays (Khan and Trentham, 2004) have shown that in 
a ∆tsr background leucine can elicit an attractant response. Moreover these studies have 
implicated Tar as being responsible for this response. However,in all of them the 
conclusions drawn were based on the behaviour of mutants which still contained different 
combinations of the other chemoreceptors. Given the extensive functional interactions 
among the different chemoreceptors (Ames et al, 2002; Gestwicki and Kiassling, 2002), 
it was considered necessary to test the effect of leucine in a Tar-only background. 
 
 
 
Fig.III-33. Chemical-in-plug assay. RP437 (wt) and UU1250/pLC113 (Tar+) cells were allowed to 
swim away from plugs containing 0.1 M of chemical for 1h at 30°C. 
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The chemical-in-plug assay was used to determine whether leucine can be recognized 
as a repellent by Tar. As described in the Materials and Methods section, wild-type 
RP437 cells and receptor-less UU1250 cells expressing Tar from plasmid pLC113 were 
exposed to plugs containing 1 mM of  either the known Tar repellent Ni2+ , as a positive 
control, aspartate, as a negative control and leucine. As shown in fig.III-33 wild-type 
E.coli swim away from nickel and leucine, forming especially in the case of leucine a 
characteristic hallow, whereas the Tar-only cells respond only to nickel. This means that 
Tar is expressed and functional in these cells and therefore failure to swim away from 
leucine represents failure of Tar to sense leucine as a repellent 
Swarm plates were used in order to test whether leucine can act as an attractant for 
Tar. Plates were prepared as described in the materials and methods section and were 
inoculated with either wild-type RP437 or UU1250/pLC113 cells.  
 
 
 
Fig.III-34. Swarm plates of wt and UU1250/pLC113 cells without inducer or with double the amount 
of inducer compared to liquid cultures. Plates were allowed to develop at 30°C for 25h. 
 
As shown in fig.III-34 wild-type cells form a characteristic disk in aspartate plates, 
while in leucine plates they form a much smaller and different pattern disk, which is 
exactly the same to the disk formed in control plates. UU1250/pLC113 cells behave 
exactly like the wild-type when Tar expression is induced, at any concentration of the 
inducer of sodium salicylate. In the absence of inducer there is absolutely no ring 
formation in any plate. The lack of a disk similar to the one in control plates of RP437 or 
UU1250/pLC113 induced cells can be simply accounted for by the fact that in the latter 
cases there is a residual taxis to the additives in the plates, while in non-induced 
UU1250/pLC113 there is no receptor to mediate any type of taxis.  
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Since both the chemical-in-plug and leucine swarm plate assays did not show any 
response to leucine through Tar it was considered possible that the effect of leucine is too 
subtle to be seen in these assays. To test this hypothesis swarm plates containing different 
ratios of aspartate and leucine were tried, in order to see if leucine can have an effect on 
the aspartate-disk formation. As shown in fig.III-35 Leucine had no effect at any ratio, 
suggesting that under the given experimental conditions there is no sensing of leucine 
through Tar and no significant competition of leucine and aspartate for binding to Tar. 
 
 
 
Fig.III-35. Swarm plates of wt and UU1250/pLC113 (Tar+) cells containing different ratios of L-
Asp:L-Leu with 1 mM L-Asp in all plates. The white bar corresponds to 1 cm. 
 
However it should be noted that the swarm plate method might not be suitable for 
studying leucine taxis, since there are two opposing factors in this particular case, which 
makes interpretation of the results very hard: On one hand, since leucine is not utilised by 
the bacteria metabolism as effectively as aspartate (see discussion), formation of the 
necessary gradient for taxis, might be impaired in the range of leucine concentrations 
used. On the other, all available strains for the study are leucine auxotrophs, which means 
that a high enough leucine concentration is required for normal cell growth. Balancing 
these two opposing driving forces is not straightforward. Therefore different methods 
were used to test whether leucine is an attractant for Tar. 
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FRET experiments 
 
Most chemotaxis assays reflect the effect of chemicals on the motor through the 
chemotaxis signalling apparatus, at different time scales. However Fluorescence 
Resonance Energy Transfer (FRET) can be exploited to see directly the effect of 
chemicals on the chemotaxis signalling apparatus in the following way: CheY is 
phosphorylated to CheY-P by CheA and CheY-P is dephospohorylated by CheZ. 
Therefore at steady state conditions for the formation of CheY-P, the level of the CheY-
P:CheZ complex should be representative of CheA activity. The levels of the complex 
can be monitored using plasmid-borne CheY-YFP and CheZ-CFP fusion proteins in a 
∆cheychez genetic background, since excitation and fluorescence of CheZ-CFP will lead 
to excitation of CheY-P-YFP only when they are complexed, changing the levels of 
fluorescence for both proteins. When plotting the ratio of fluorescence of YFP/CFP, the 
plot follows the effect of chemicals on CheA activity i.e. attractants, which down-
regulate CheA activity, reduce the YFP/CFP ratio, while repellents have the opposite 
effect. As shown in figure III-36 VS104 (wild-type) cells show a decrease in the 
YFP/CFP ratio upon aspartate addition and then show a pseudo-repellent behaviour upon 
removal of aspartate (washing with buffer) caused by the adaptation machinery. Leucine, 
in accordance to the other assays, acts as a repellent for the wt cells. 
However for receptor-less cells (VS181) which express only Tar from pLC113 the 
pattern is more complicated: Although aspartate gives the same behaviour as for the wt, 
leucine gives a kind of biphasic response: it first elicits an oscillatory repellent response 
(2 peaks), but with time instead of adapting, the sign of the response is inverted into that 
of an attractant. The attractant part of the response seems to be greater than the repellent. 
Removal of leucine, by washing with buffer, results in pattern which looks like the  
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Fig.III-36. FRET experiments cells exposed to 10 µM L-Asp and 10 mM L-Leu (A)  wt cells (B) 
Receptor-less cells expressing Tar from pLC113 (C) Receptor-less and ∆cheBcheR cells expressing Tar 
from pLC113 
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inverted response, suggesting that leucine is initially “remembered” the way it evoked the 
very first response. This could reflect an over-shoot or generally an implication of the 
adaptation machinery. Therefore the same experiment was repeated with cells carrying 
only Aer and expressing Tar, which are ∆cheBcheR (VS164). In this case cells failed to 
adapt to aspartate, as expected, but behaved in a surprising way towards leucine: the 
response was that of an attractant, but it was followed by adaptation of the cells in the sa-
me way that cells adapt to aspartate in the presence of CheB and CheR. Furthermore, 
when Tar expression is not induced in these cells, they do not respond at all to leucine. 
These results clearly shows that Tar is essential for mediating the response to leucine, but 
the mechanism by which leucine is sensed is different and much more complex than that 
for aspartate. Moreover there seems to be an additional adaptation pathway, which is 
specific for only some stimuli. 
This interesting finding raises some questions like whether leucine is binding directly 
to Tar or through a binding protein and whether the alternative adaptation machinery acts 
on Tar or on a different protein binding to Tar. Competition experiments with the 
adaptation deficient cells between L-aspartate and L-leucine showed that in fact there is 
no competition, i.e. at all ratios of aspartate/leucine tried the response was that for 
aspartate (data not shown). This fact not only indicates that aspartate and leucine are 
sensed in a different way, but also the mechanism by which adaptation takes place for 
leucine in the ∆cheBcheR cells does not have any effect on aspartate sensing, since in the 
presence of both amino acids the signal for aspartate is the same as in the absence of 
leucine. 
Although this finding could suggest that leucine is acting through a periplasmic 
binding protein, no evidence was found to support this hypothesis. The only two known 
candidates, which are involved in amino acid transport, seem not to be involved: one of 
them, LivJ, is specific for leucine transport and the other. LivK, is responsible for the 
transfer of leucine, valine and isoleucine (Adams et al, 1990). Valine gives a similar 
pattern to leucine which rules out the possibility that LivJ is responsible for the 
phenomenon, while isoleucine does not give the same pattern, making it highly unlikely 
for LivK to be involved. 
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Fig. III-37. FRET experiments with receptor-less cells, expressing Tar from pLC113, exposed to 10 
mM of the respective amino acid. 
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From the amino acids that were found to inhibit Taz, L-valine, L-serine and L-
histidine showed a similar response to L-leucine, although the response to serine was not 
as profound as for the others. However L-methionine acted as a normal attractant (fig.III-
37), L-valine, L-serine and L-histidine apart from giving a complex pattern in adaptation 
wt cells, were also sensed as attractants by Tar in ∆cheBcheR genetic background (fig.III-
38) and showed adaptation (data not shown). 
 
 
Fig.III-38. Response in FRET units, which also reflects the degree of CheA inhibition, of receptor-less 
∆cheBcheR cells expressing Tar from pLC113 to 20 µM L-Asp and 10 mM of the other L-amino acids. The 
results represent the average of three experiments. 
 
 It is worth noting that all these responses are evoked only in the mili-molar range and 
not in the micro-molar as for aspartate and as expected for chemoeffectors, although with 
different techniques leucine has been shown to elicit a response even in the miro-molar 
range (Mao et al, 2003; Khan and Trentham, 2004). However this does not affect the 
significance of the response, since it is only seen when Tar is expressed and thus it 
reflects a true sensing property of the receptor. Moreover it is rather intriguing that 
although the affinity of the chimera Taz for Asp is lowered to the mili-molar range, its 
affinity for the other amino acids seems to increase by one order of magnitude. As far as 
the stereospecificity is concerned D-aspartate was recognised by Tar but also D-leucine 
elicited a response quite similar to the L- optical isomer. Therefore, there seem to be 
some common features between the behaviour of the chimera and Tar, as shown by 
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FRET experiments, but also distinct differences. Discrepancies between FRET 
experiments and chemotaxis assays are considered in the discussion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part IV 
Discussion 
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The Taz-OmpR-ompC system 
 
In the original study by Utsumi et al the chimeric system was found only to be 
activated by some ligands like L-aspartate. The aim of this study was to use this system 
as a template in order to built a novel signal transduction pathway whose output would be 
regulated by a gene network. However intrinsic properties of the parent systems and 
unexpected results rising during the study, like the fact that some amino acids, like L-
leucine, can down-regulate expression of GFP from pompC, made it necessary to re-
address some of the basic properties of the system and to refocus the objectives of the 
Thesis into a re-examination of the chemotatctic process in E. coli.  
 
Responsiveness of the Taz-OmpR-pompC system in respect to cell growth 
 
It has already been shown by Martinez-Flores et al that the wild-type EnvZ-OmpR 
system in E.coli, retains its responsiveness until the mid-logarithmic phase, after which it 
is activated by an unknown mechanism. Although in that study the rate of production and 
degradation of the porins was not measured or taken into account, in order to distinguish 
between net accumulation of the porins and actual activation of the system, in this study 
it is clearly shown that this activation indeed takes place: BL21(DE3) cells carrying the 
reporter plasmid pR2 with the destabilised GFP(LVA) under a minimal pompC were 
responsive to osmotic shock only until mid-logarithmic phase and cells in stationary 
phase exhibited the same levels of GFP, independently of exposure to 0.3 M NaCl or not. 
Such a cross-talking system could have serious implications for the chimeric system, 
since it is not known how it would behave in the context of Taz. Therefore, as a starting 
point all experiments had to be carried out at the beginning of the logarithmic phase. In 
contrast to the osmotic shock experiments, when minimal media containing the putative 
signal were inoculated, cells showed a lag phase of 5-6 hours longer than the control 
cells. In order to overcome this problem cells were inoculated in media without any 
putative signal, allowed to grow until they enter into exponential phase (OD600= 0.150- 
0.200) and subsequently exposed for 1h to the chemical, so that cells do not exceed the 
mid-logarithmic phase. This way the cultures retained their synchrony in growth, while 
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being exposed to the signal for a short time-frame, sufficient for gene expression, but too 
short for great changes in the signal concentration by metabolism. 
In the context of the chimeric receptor, instead of EnvZ, cells appeared to be less 
sensitive to this activation. Cells at any point of cell growth, ranging from early 
exponential phase to stationary phase were equally responsive to signals (L-aspartate  and 
L-leucine). This is manifested for aspartate by the fact that when the GFP levels at each 
time point are normalized to the first data point of the time series, they are approximately 
the same, indicating that the activation of the system is the same regardless of the phase 
of cell growth. However when monitoring the change in levels of GFP in non-stimulated 
cells with time, it is clear that cells at the beginning of exponential growth have already 
accumulated a substantial amount of GFP which decays until the stationary phase. 
Therefore, in the case of leucine, normalizing each data point to the respective data point 
for the control cells, shows that the decrease in GFP levels is the same at any point of the 
growth curve.  
Overnight cultures show an increase in GFP and lose their responsiveness to any 
stimuli (L-aspartate or L-leucine), which means that somehow the system is activated at 
late stationary phase. Further accumulation during the lag phase cannot be excluded 
either. Activation by release of amino acids through cell death can probably be excluded, 
since the number of activating amino acids is much smaller than that of the inhibitory and 
the effect of the inhibitory amino acids is dominant over the stimulatory effect of L-
aspartate even at 10-fold lower concentrations. Taking into account the quantile 
distribution of amino acids in E.coli proteins (Karlin et al, 1992 ), it is almost impossible 
for the concentration of free aspartate and glutamate to be enough to overcome the 
inhibitory effect of other amino acids. For example, in strain E.coli B/r under aerobic 
conditions and in rich media the sum of the inhibitory amino acids (leu, met, ser, val and 
his) is 1271 µmol/g of dried cells, whereas the sum of activating (asp and glu) and their 
precursors (asn and gln) is only 958 µmol/g (Neidhart et al, ). On the other hand, release 
of a different, uncharacterised, dominant signal rising from cell death cannot be excluded. 
The most likely possibility appears to be that the system which activates porin 
expression in the wild-type system is also responsible for GFP accumulation in the 
chimeric system. However, since this activation is not as efficient as in the case of the 
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wild-type system and since it is absent in cells without EnvZ or Taz, it seems that it 
requires at least EnvZ-C in order to take place and that Taz either lacks some important 
element of EnvZ or has an altered structure of EnvZ-C so that the activation cannot take 
place earlier than in the very late stationary phase. 
The change in the growth-dependent activation of the system gives several advantages 
to the chimeric system. First of all accumulation of GFP until the entry into exponential 
phase, in combination with the short half-life of the GFP used, allows detection of 
inhibition of the system. Otherwise there would not be a detectable difference between 
the control and the inhibitory signals as was the case in the original study of Utsumi et al, 
where the long half-life of the reporter, LacZ, (Bergquist and Truman, 1978) masked the 
inhibitory effect of L-serine. Moreover the chimeric system is freed from the time 
constraint as far as responsiveness is concerned: exposure to any signal can be done at 
any point of the growth curve. However there is an extra advantage for the sensitivity of 
the measurements: since the level of GFP is decaying in non-stimulated cells, signals 
which activate the system will show an increasing difference from the control at a given 
time point as cells progress through the growth curve, while the opposite stands for 
inhibitory signals. Therefore the effect of inhibitory signals can be monitored with higher 
sensitivity at the beginning of the growth curve, while the effect of activating signals can 
be monitored with higher sensitivity at latter time points, e.g. the mid-logarithmic phase. 
 
 
Complex reporter constructs 
 
As expected by the noise in gene expression, non induced cultures should contain a 
significant amount of fluorescent cells and cultures exposed to a signal should contain a 
significant number of cells with low or zero fluorescence (Becskei et al, 2001). Therefore 
different types of gene circuitry were designed in order to control more tightly the output 
of the pathway. Unfortunately one of the constructs (pR5), which would also serve as the 
basis for the others, appeared to be toxic.  
In this construct TetR was supposed to be expressed from a synthetic promoter, which 
contained the OR1 site for CI between the –35 and –10 regions and repress expression 
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from pompC by binding to a mutant TetO1 site that overlapped with C1. Activation 
would take place only when OmpR-P levels would be high enough to out-compete TetR 
for binding to C1 and if the level of TetR expression would have been too high, 
activation could be fine-tuned by adding traces of aTc. However all initial attempts to 
clone the synthetic promoter-tetR fragment failed, giving either no clones or clones in 
which the synthetic promoter was destroyed by mutations and deletions in the conserved 
regions. 
This peculiar phenomenon was initially attributed to the fact the synthetic promoter 
and pompC,  were divergent promoters with a short spacer in between, possibly affecting 
the system through accumulation of negative supercoling (Wu et al, 1988; Wu et al 
1995). In order to test this hypothesis the promoter-less araC gene was introduced so that 
the spacer was approximately 800 bp long This fragment was chosen simply because it 
pre-existed in the plasmid backbone and was removed during the cloning of tetR. The 
clones obtained still had mutations but it was possible to obtain a single point mutant and 
to correct it with PCR-ATW. In order to be sure that the PCR did not introduce any 
mutations in the rest of the construct, the spacer-promoter-tetR fragment was excised and 
re-cloned into pR4. Sequencing of the construct, even after several generations showed 
that the sequence remained intact, suggesting that the problem of toxicity had been 
overcome. Therefore the other constructs, pR6 and pR7 were also constructed using pR5 
as a starting material.  
Moreover, the single point mutant promoter was also used for making the respective 
constructs, since the mutation T-36C is expected to only reduce promoter strength (Vo et 
al, 2003), allowing to explore a bigger part of the parameter space. However when 
functionally tested, the constructs with the mutant promoter showed similar behaviour to 
the simple systems pR1, pR2, suggesting that the mutant promoter is too weak to have an 
effect. Construct pR7C, which has the temperature sensitive CI as a transcriptional fusion 
to gfp, gave much lower levels of GFP. A possible reason for this is that the cells did not 
grow in the specific medium at the permissive temperature (30°C) and the experiment 
had to be carried out at 37°C, which is close to the non-permissive temperature (42°C). 
Thus, for pR7C, lower GFP levels could be due to a fitness problem of the cells caused 
by partially denatured CI. 
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On the other hand cells with the desired synthetic promoter showed no GFP 
expression, even when activated with aspartate. Although this could be due to too tight 
repression, it was rather puzzling that repression could be so efficient for the anti-sense 
RNA construct (pR6) and that addition of aTc could not relieve repression by TetR. TetR 
expression from both mutant and wild-type promoter was tested by western blot analysis 
using a mixture of monoclonal anti-TetR antibodies and surprisingly only the mutant 
promoter expressed TetR. As expected, the expression level was much lower than that for 
control cells (DH5aZ1) which produce enough TetR for tight repression of TetR-
regulated promoters (Lutz and Bujard, 1997). However it was not clear why in pR5 both 
the designed promoter and pompC were completely silent. Thus pR5 was sequenced 
again and no mutation, insertion or deletion was found in either promoter or gene. 
However diagnostic PCR with different primers revealed the insertion of a 1.2 kb DNA 
fragment downstream of gfp. This fragment was partially sequenced and was found to 
correspond to part of the transposase gene from Tn10, containing several stop codons in-
frame with the gene. Although it is puzzling how this fragment was inserted, the 
mechanism by which it silences the two promoters is even less clear. However this 
insertion seems to be the only plausible explanation why the sequence of the construct 
remained intact: silencing the system indirectly probably relieved the cells from the 
toxicity problem, without needing to mutate the cloned sequences. 
The reason for the toxicity of the construct remains elusive, but it is further 
demonstrated by the fact that when the correct sequence of spacer-promoter-tetR is 
excised from pR5 and re-cloned in pR4, all of the clones tested have undergone 
recombination, which affects expression of either TetR or both TetR and GFP, although 
the cells used are recA-. 
 
 
Alternative fusion points 
 
Since the sensitivity of Taz is approximately 1000-fold lower than Tar, it was tested if 
shifting the point of fusion of the two receptors can change the sensitivity of the chimera 
in a favourable way. It should be pointed out however that in any case it would be highly 
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unlikely to reach the same levels of sensitivity as wild-type Tar, since its sensitivity is 
enhanced by two factors which are absent in the case of the chimera: the lattice formation 
and the adaptation machinery. Based on the sequence alignment of the two receptors, 
three new points were chosen resulting in the three additional chimeric receptors H1, H2 
and H3, which contain increasing fragments of the Tar linker region. From these 
receptors H3 had a basal level of GFP expression and did not respond to aspartate, while 
H1 and H2 showed a barely detectable GFP expression level.  
The behaviour of H1 and H2 could either reflect a defect of these receptors in the 
phospho-transfer reactions or a problem of their stability and expression. Since there 
seems to be a very small level of GFP expression the former seems to be the most 
probable explanation.  
Furthermore, while we were finishing our study, similar fusion variants were shown 
by Zhu and Inouye to exhibit the same behaviour as in our case and for some seemingly 
inactive receptors, like Tez1, activity could be restored by mutations in the linker (in the 
case of Tez1 P185Q). Apparently, as shown in the latter study, the register of the helices 
in the linker, but also the sequence itself is crucial for the function of the chimera. Since 
in our case the fusion is based on a sequence alignment and does not change the register 
of the helices, it seems that the exact sequence of the linker plays a dominant role.   
 
 
Rational design of Taz mutants with altered specificity 
 
According to the original study on Taz by Utsumi et al L-serine and other ligands 
were not sensed by Taz, while the only effect observed was activation by L-aspartate and 
its α-methyl-ester. Therefore it was assumed that it could be possible to switch specificity 
of the receptor from L-aspartate to either L-leucine, L-glutamine, L-serine or L-threonine 
through rational design. These signals were chosen on the basis of similarity to the 
original signal according to their structure (leucine), structure and polarity (glutamine) 
and the fact that the serine receptor has an almost identical binding site for serine. In 
order for any design to be successful it is necessary to use a template of good quality. 
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As a template the crystal structure of the Tar periplasmic domain from Salmonella 
typhimurium in complex with one aspartate molecule was chosen, because it is the best 
available structure and it is probably closer to the structure of Tar from E.coli, where only 
one aspartate molecule can bind due to negative co-operativity. The quality of the 
structure and its predictive power were assessed by using the Perla, SwissPdbViewer and 
Fold-X algorithms to calculate the dissociation constants of aspartate for various 
mutations in the binding pocket which have already been experimentally measured. The 
predictions follow the trend of the experimental data and at least for the wild-type system 
it seems that the predictive power of the algorithms with this template is quite good. 
When other amino acids are placed in the position of aspartate the Kd values for the 
respective complex are much higher than those for aspartate and glutamate, suggesting 
that if the receptor has any affinity for other amino acids it would be too low compared to 
the normal signals. Therefore trying to switch affinity towards leucine, glutamine, serine 
and threonine seems reasonable. 
In silico mutations in the binding pocket were done using the Perla algorithm. The 
energy of the generated structures was minimized with SwissPdbViewer and the energy 
of interaction, from which the Kd was calculated was determined with Fold-X. In the case 
of leucine and glutamine all different combination of amino acids at the critical residues 
were tried and only the best structure was chosen to be tested for each receptor. However 
the design for TaQ was not very good and looking at the putative structure it seems that 
the binding pocket is filled by the chosen residues, without leaving space for a ligand. 
Even the best structures, although they have increased affinity for the respective ligand, 
are predicted to have weaker interaction with the new ligand compared to the aspartate-
wild-type Tar interaction. In fact in the case of serine and threonine the serine (or 
threonine)- mutant Tar interaction is predicted to be weaker than the aspartate-mutant 
Tar, although the mutations in this case were not random but specifically selected so that 
they re-constitute the binding pocket of the serine receptor, Tsr. This raises the question 
how selectivity is achieved in Tsr and whether there is a different conformation or 
conformational change that could account for serine specificity in Tsr. 
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Behaviour of the designed receptors 
 
The behaviour of the designed receptors was far from what was expected. TaQ is 
constitutively active and none of the amino acids tested had an effect on GFP levels. 
Cells expressing TaS were not activated by L-Ser, L-Thr but were activated by L-Asp 
and cells expressing TaT showed a low basal level of GFP and were not responsive to 
any amino acid tested. In the latter case probably the R69K and R73M substitutions 
abolished ligand-binding rather than providing more space for the methyl group of L-Thr. 
However the biggest surprise was TaL which had a significantly high basal level and in 
the presence of L-leucine there was a drastic drop in GFP levels which unexpectedly was 
also seen in the case of Taz. The discrepancies between predictions and experimental 
results can be explained if a conformational change in the periplasmic domain is induced 
by the fusion to the cytoplasmic domain of EnvZ. This hypothesis could be tested in the 
future by the simple fact that the predictive power of the method is acceptable for the 
wild-type Tar and therefore making the respective substitutions to wild-type Tar should 
shift the affinity of the wild-type receptor for the respective ligands.  
 
TaS and the Tsr-Taz variant  
 
The failure of TaS to recognize L-Ser and the ability to recognize L-Asp, although 
they were in agreement with the theoretical prediction, were rather puzzling, since the 
mutations made should re-constitute the core of the ligand binding pocket of Tsr.  
Although the differences in the binding pocket are few and we have converted one into 
another, there are differences outside which could modify the structure of the receptor 
and provide specificity towards Ser.  In order to check this, different fusions of Tsr to 
EnvZ or Taz were constructed and also 2 more mutations (in the vicinity of the binding 
site) were introduced in order to match as possible the binding pocket of Tsr. 
Surprizingly Tsz, which is the equivalent to Taz Tsr-EnvZ chimera, was not functional. 
Although there was a basal level of GFP expression, which suggests that the chimera is 
expressed, there was no effect of any of the amino acids tested. A possible explanation 
would be the following: the strain used for the study, AT142, has the flhD5301 mutation 
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and therefore does not express Tar and most of the chemotaxis genes. However it has not 
been shown whether Trg and Tsr expression is also dependent on the FlhC/FlhD activator 
and thus it is plausible that there is expression of Tsr and formation of hetero-dimers with 
chimeric monomers which would prevent normal signal transduction. Such a hypothesis 
cannot be rejected on the basis that the Trg-EnvZ chimera, Trz, is functional 
(Baumgartner et al, 1994) since Trg, in contrast to Tsr, is a low abundance receptor and 
its levels are probably too low to interfere with the chimera. However the western blots 
with anti-MCP serum for strains with different or no receptors and AT142, clearly show 
that there is no Tsr expression in AT142. The only bands observed corresponded to non-
specific binding. Therefore it seems that the orientation of the extracellular part of the 
receptor in Tsr is very different from that in Tar, and therefore linking at the same 
position abolishes functionality of the receptor, despite the apparent similarity in the 
binding pocket. 
This hypothesis is supported by the fact that using the structure of Tar as a template 
the designed Tsr binding domains (TaS and TSNI) are predicted to have a much higher 
affinity for aspartate than for serine and by the behaviour of the other constructs. Tsaz is 
locked in a non-responsive very low basal level state, like Tsz, but TSNI and Tasz show 
an intrinsic pattern: The basal level of the receptor seems to be saturating, like to that for 
activation of Taz by Asp. L-Asp does not seem to have any effect, but L-Ser inhibits both 
receptors. Furthermore, the rest of the inhibitory aa for Taz, seem to have an inhibitory 
effect on both TSNI and TasZ which is however more profound for TSNI. Therefore just 
by mutating 4 residues in the ligand-binding domain of Taz to the respective ones in Tsr, 
it is possible to approximate the behaviour of the whole ligand binding domain of Tsr. 
 
TaL and its variants 
 
The fact that cells expressing TaL showed down-regulation of GFP expression upon 
exposure to leucine, was exactly the opposite of what was desired. Therefore the 
possibility of changing the sign of the response was tested by introducing only mutations 
R69M and R73M, which should favour the interaction with the hydrophobic side-chain 
of leucine in a similar way that the respective arginines interact with the charged side 
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chain of aspartate in the wild-type case. However the resultant receptor, TaLM, showed a 
very low basal level and no responsiveness to leucine. In order to understand the 
significant difference between TaLM and TaL, single mutants were tested (R69M, R69L, 
R73M) which unfortunately could not give more information apart from demonstrating 
the importance of residues 69 and 73 in signal sensing. The only plausible explanation 
seems to be that the combination of mutations in TaL result in a conformational change 
of the receptor which has a high basal level of activity and retains a certain degree of 
responsiveness to leucine. This explanation, versus a change of the interactions of the 
mutated residue  with the ligand, is supported by the observation that mutations in the 
ligand binding domain can have very different and drastic effects on Taz (Yang et al, 
1993): the R64C substitution renders Taz constitutively active, whereas the R69H or 
R73Q substitutions eliminate the sensing properties of Taz without changing its baseline 
kinase and phosphatase activities  
 
 
Re-examination of the sensing properties of Taz 
 
The fact that cells with either TaL and Taz showed down-regulation of GFP 
expression upon exposure to leucine raised a lot of questions about the actual sensing 
properties of Taz. In the original work by Utsumi et al, Taz failed to recognize maltose. 
However under both their and our experimental conditions, expression of the activator 
which is encoded by malT and is responsible for expression of the maltose response 
genes, including the Maltose-Binding-Protein (MBP), is repressed by OmpR (Case et al, 
1986). Therefore the responsiveness of Taz was re-examined only for the 20 naturally 
occurring amino acids. Apart from L-aspartate, L-glutamate activated the system and L-
proline elicited a weak activation at much higher concentration (20 mM). Most of the 
other amino acids had no significant effect with the exceptions of L-Leu, L-Met, L-Ser, 
L-Val and L-His which down-regulated GFP expression. Within the time-frame of the 
experiment this decrease was in the order of 40-50%, but when cells were exposed to 
leucine for longer time periods, then the levels of GFP decayed exactly as theoretically 
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predicted in the case of complete cessation of GFP production upon exposure to the 
signal, i.e. leucine, while taking into account cell growth. 
This means that the inhibitory amino acids and especially leucine manage to 
completely shut-down GFP production. However there is a possibility that this effect is 
caused by proteins other than the receptor. This seemed quite possible especially for 
leucine, since the cloned region of the pompC contains four binding sites for Lrp. The 
latter possibility was excluded on the basis that the locked-on TaQ was not affected by 
leucine, whereas in the competition experiments with Taz, the inhibitory effect of leucine 
was dominant even at 25-fold lower concentrations than aspartate. These two findings 
suggest that the effect of leucine cannot be in the part of the signalling pathway that is 
below the receptor-level and that Lrp cannot compete with the level of OmpR-P produced 
by an active receptor, provided that the levels of OmpR-P generated by activated Taz and 
the locked-on TaQ are within the same range. This assumption is quite safe to make, 
since as shown by the response curves , the wild-type chimeric system is 10-fold more 
sensitive to leucine than aspartate and thus if there were an effect through Lrp, the 
locked-on mutant receptor would have to produce 10-fold more OmpR-P than Taz. The 
latter is highly unlikely since it has been shown that the amount of OmpR-P needed to 
activate transcription from pompC is 10% of the total amount of OmpR molecules inside 
the cell (Cai and Inouye, 2002). 
Furthermore, the wild-type EnvZ-OmpR system was shown not to be affected at all by 
leucine, suggesting together with the aforementioned results that leucine interacts with 
the Tar moiety of the chimera. Such a result, would have interesting implications for the 
wild type chemotaxis system, if the conformational changes upon ligand binding in Taz 
and Tar are co-related. 
 
 
Examination of leucine effect on chemotaxis 
 
If the conformational changes in Taz and Tar, which are induced upon ligand binding, 
are co-related then since aspartate is an attractant for Tar and elicits an opposite response 
to leucine through Taz, leucine would be expected to be sensed as a repellent by Tar. 
Discussion 96
However, early chemotaxis studies have shown that Tsr recognises leucine as a repellent 
and more recent ones have shown that leucine can elicit an attractant response in a ∆tsr 
background, possibly through Tar. Since all of these studies used deletion mutants which 
still had different combinations of some chemoreceptors and it the extensive functional 
interactions between the different types of chemoreceptors are well established, it was 
necessary to test the effect of leucine on cells expressing only Tar from a plasmid 
(UU1250/pLC113).  
In this context, the chemical-in-plug assay, which is a typical experiment for 
repellents, showed that although Tar is expressed and functional under the experimental 
conditions (cells swimming away from nickel), it does not sense leucine as a repellent. 
The swarm-plate assay, which is a typical assay for metabolizable attractants, again 
showed the expected pattern of an attractant response for aspartate and the pattern for 
leucine was exactly the same to the control, for both wild-type and Tar-only cells. The 
pattern for the control was a very small disk, different from that for aspartate and 
probably it can be attributed to basal taxis towards additives in the plates, since non –
induced UU1250/pLC113 cells, which have no chemoreceptors, failed to move further 
than the point of inoculation. Swarm plates with different ratios of aspartate and leucine 
also showed no difference to aspartate-only plates, suggesting that there is no competition 
between aspartate and leucine and that leucine cannot affect the response to aspartate. 
It should be pointed out that failure of cells to form a disk in leucine plates similar to 
that in aspartate plates does not necessarily exclude the possibility that leucine can act as 
an attractant. The problem in interpreting the results for leucine rises from the differences 
in amino acid metabolism and also from the fact that all strains used are leucine 
auxotrophs. In order to form a disk the cells must metabolize the chemical with a certain 
rate, so that a gradient can be formed and act as the driving force for taxis. Leucine 
cannot be utilised as efficiently as aspartate: aspartate can be used either as a carbon or 
nitrogen source through the reactions L-asp + 2-oxolutarate → L-glu+ oxaloacetate and 
L-asp → fumarate + NH4+ (Neidhart et al;  Goux et al, 1995), whereas leucine is mainly 
used for protein synthesis. Therefore a gradient will probably form only at much lower 
concentrations of leucine than asparatate. However, since the cells are leucine 
auxotrophs, they already require a substantial amount of leucine for growth, which could 
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be limiting the gradient formation. Balancing these two opposing needs is not 
straightforward and thus the swarm plate assay is probably not a reliable method in the 
case of leucine. 
FRET experiments with cells which are also ∆cheYcheZ, but express the plasmid-
borne fusions CheY-YFP, CheZ-CFP can by-pass this obstacle. Cells carrying all 
receptors respond as previously described: aspartate acts as an attractant and leucine as a 
repellent. In this case, when cells are exposed to aspartate, the ratio of fluorescence for 
YFP/CFP (R) decreases because CheY phosphorylation is down-regulated and as time 
progresses cells adapt and the ratio returns to the basal level. If aspartate is removed by 
washing with buffer then the cells give an attractant-removal response, which looks like a 
repellent response. This pseudo-repellent response is manifested as an increase in R and 
is caused by the adaptation machinery. However when cells expressing only Tar are used, 
although the response to aspartate remains the same, leucine generates an intrinsic, 
“biphasic” response: cells respond in the beginning as if leucine is a repellent and as time 
progresses, instead of adapting, they switch the sign of the response to that of an 
attractant. Upon leucine removal the pattern generated is the inverted one. This means 
that cells keep in “memory” the very first reaction to leucine and give first an attractant 
removal response followed by a repellent removal response. . L-Valine, L-Serine and L-
Histidine had a similar effect, whereas L-Methionine behaved as a normal attractant.. In 
cells without Tar there was no response which indicates that Tar is essential for the 
response. 
Since this peculiar pattern resembles an over-shoot in adaptation, the same experiment 
was carried out with cells lacking the known adaptation machinery (∆cheBcheR cells), to 
test if/how the adaptation machinery is involved in this complex behaviour. When the 
cells are exposed to aspartate, they show the expected drop in R, fail to adapt and do not 
give the attractant-removal response when washed with buffer. When they are exposed to 
leucine the respond is that of a normal attractant, but surprizingly there is adaptation in a 
time-frame and manner similar to that for aspartate in wild-type strains. The same is true 
for valine, serine and histidine.. This finding clearly demonstrates that the CheB-CheR 
machinery plays an important role in the biphasic response, but also that there is an 
additional adaptation mechanism. When the same strain is exposed to different ratios of 
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aspartate to leucine the behaviour of the cells is exactly the same to that for the respective 
concentration of aspartate, as if leucine has no effect, even at 10-fold higher 
concentrations of leucine. An obvious explanation for this could be that aspartate out-
competes leucine for binding either preventing binding to the same site or changing the 
conformation of the receptor in a way which prevents leucine binding to a different site. 
However there are still more possibilities which could account for this phenomenon and 
should be considered. 
One alternative explanation is that leucine interacts with Tar through one or more 
different proteins and that the second adaptation machinery acts on that level. Therefore 
when leucine and aspartate are used together in ∆cheBcheR cells, adaptation for aspartate 
is not seen because the adaptation machinery works not directly on Tar, but on the 
proteins involved in the leucine response. The only known periplasmic proteins which 
bind leucine are LivJ and LivK, which are both involved in amino acid transport inside 
the cell (Adams et al, 1990). LivJ is specific for leucine, whereas LivK is specific for 
leucine, valine and isoleucine. Since cells, of either adaptation background, show similar 
responses for leucine, valine and histidine, but not for isoleucine, it seems unlikely that 
any of these two binding proteins is mediating the response. However the possibility that 
non-characterised periplasmic and or transmembrane proteins are involved cannot be 
excluded. 
Another explanation is that leucine binds indirectly to Tar or even directly either at the 
same or a different site to aspartate, but induces a different conformational change which 
renders Tar susceptible to a different type of adaptation machinery. This conformation 
and modification of Tar would be specific for leucine (valine, serine and histidine) but 
would not have an impact on aspartate sensing. In other words this type of modification 
for adaptation to leucine would not infer adaptation to aspartate. This hypothesis can be 
partially tested by trying to identify possible modifications of Tar in the presence of 
leucine other than methylation. The fact that leucine and the other amino acids are sensed 
in a different way than aspartate is further supported by the fact that in the FRET 
experiments the sensitivity of the wt system is within the micro-molar range for aspartate 
and within the mili-molar range for the other amino acids, whereas in the chimera the 
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affinity for aspartate is within the mili-molar range and the affinity for the other amino 
acids is slightly increased. 
In any case it is not possible to distinguish between leucine binding directly to the 
same site as aspartate, to a different site or indirectly through a protein complex, by 
competition. Mutagenesis of the aspartate binding pocket is also not very informative or 
straightforward to explain, since in either context (Taz or Tar) mutations can lead to 
global conformational changes affecting the signalling properties of the receptor, instead 
of simply interfering with ligand binding.  
It is clear that leucine sensing through Tar is a very complicated phenomenon, 
involving proteins which are not yet characterised. The fact that leucine gives a complex 
response in FRET experiments, but a more simple attractant response in capillary, 
tethered cell and some swarm-plate assays could be easily accounted for the fact that the 
latter assays reflect the behaviour of the whole system, including the motor, whereas 
FRET reflects only what happens at the signal transduction level and possibly the net 
effect under the experimental conditions of the other assays is that of the attractant, which 
would be the same for the FRET experiments if the two phases of the response were 
integrated. 
 
 
Implications of Tar responses for Taz 
 
Taking into account all the aforementioned possibilities it is clear that leucine, valine 
and histidine sensing by the chimera is a remnant from Tar. However the exact sign of 
the response by Taz is not related to that in Tar: attractants like aspartate and glutamate 
activate Taz, while attractants like leucine and methionine and can inhibit Taz. This 
indicates that the conformation of the periplasmic domain of Tar in the context of the 
chimera is different to that of wild-type Tar. Such a possibility could also account for the 
1000-fold lower apparent affinity of Taz for aspartate than Tar, although the fact that the 
sensitivity of Tar is enhanced through the lattice formation and the adaptation machinery 
should be taken into consideration. Moreover this conformational change could also 
account for the failure of the design to change ligand specificity and reflects the problems 
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in rational design rising from having resolved structures of only fragments of 
transmembrane proteins. As discussed above there were several discrepancies between 
theoretical predictions and experimental results with the most intriguing being the 
predicted failure of the reconstituted Tsr binding domain to bind serine with higher 
affinity than aspartate. Such discrepancies imply that the available crystal structures do 
not provide the whole ensemble of conformations of the chemoreceptors, making rational 
design very difficult. As already seen in the results section, the apo and ligand bound 
structures exhibit differences which are within the error of structure determination and 
therefore appear to be probably crystallisation artefacts, rather than true conformational 
changes. Taking as well into account the fact that the structures correspond only to the 
periplasmic domain, it is impossible to tell which is the true apo conformation in the 
whole receptor and especially in the case of the chimera, where the different cytoplasmic 
region can change the orientation of the subunits even more.  
Despite these problems the fact that Taz responds, although in an intrinsic manner, to 
signals of Tar displays the flexibilty of the chemoreceptors. This flexibility is highlighted 
by different chimeras either between the chemoreceptors themselves (Tap-Tar, Tar-Tsr) 
or chememoreceptors and other receptors (Tar-insulin receptor, Trg-EnvZ, NarX-Tar)  In 
the former case the properties of the chimera are more close to the N-terminal parental 
receptor, i.e. the Tap-Tar hybrid senses dipeptides exactly like Tap. In the other case the 
effect of the signalling molecule(s) can is either closer to the response of the N-terminal 
receptor,  i.e. the NarX-Tar chimera has higher affinity for nitrate than nitrite like wt 
NarX (Ward et al, 2002), or closer to the way that the C-terminal receptor would interpret 
it. For example, in the cases of Trz, Taz and the Tar-insulin receptor chimera, ribose and 
aspartate respectively are sensed by the correct sensing domain but result in a net increase 
of the kinase activity of the receptor as is expected during sensing through wt EnvZ or the 
insulin receptor.    
In any case, while the opposite is not true, any signal sensed by a chimeric receptor 
appears to be a signal for at least one of the parental receptors regardless of its net effect. 
However, depending on the affinity of the parental receptor and the limitations of the 
methods used for studying the parental system, sometimes such ligands remain 
uncharacterised. This is very well manifested in this study where amino acids which were 
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thought not to be recognised by Tar according to classical chemotaxis techniques, were 
shown to be Tar ligands with FRET experiments. In fact the FRET experiments revealed  
new aspects of chemotaxis:  
a) signals can have a complicated response which is seen as a net attractant, repellent 
or neutral response with other assays because of integration of the whole response with 
time  
b) there is an additional adaptation mechanism to that of methylation, which is specific 
for some but not all of the ligands of a chemoreceptor and acts within the same time 
range as the methylation dependent adaptation. How this is achieved is not clear but 
periplasmic binding proteins do not seem to play a role, as discussed earlier. 
The peculiarities of the crystal structures together with the results of FRET 
experiments with cells expressing only one receptor clearly demonstrate that although 
there are a lot of data on bacterial chemotaxis, we actually know much less than we 
thought about the molecular mechanism of signal transduction and chemotaxis itself in 
E.coli, Actually since most of the experiments in the past have been done with single or 
double deletion mutants of the chemoreceptors or with not well defined mutants it is 
necessary to re-evaluate the data on chemotaxis using strains with better defined 
genotype, expressing  a single chemoreceptor species. It should be noted that deletion 
mutants which have been used up to now usually express non-functional parts of the 
deleted chemoreceptors. Comparing the response of these strains, carrying the 
chemoreceptor in a plasmid, to that of “clean” deletion mutants, the amplitude of the 
response is much higher (Sourjik, V., personal communication). This further 
demonstrates the little knowledge that is available on the receptor lattice and signalling 
complex formation and should be taken into account when looking at the properties of 
single receptors.  
References 102
Abouhamad, W.N. et al (1998) Computer-aided resolution of an experimental paradox in 
bacterial chemotaxis, J. Bacteriol., 180, 3757-3764. 
 
Adams MD, Wagner LM, Graddis TJ, Landick R, Antonucci TK, Gibson AL, Oxender 
DL. (1990) Nucleotide sequence and genetic characterization reveal six essential genes 
for the LIV-I and LS transport systems of Escherichia coli, J Biol Chem., 265, 11436-
11443. 
 
Alberts et al Molecular biology of the Cell, 3rd edition, 1994, Garland Publishing, New 
York. 
 
Ames, P., Studdert C.A., Reiser, H.R., Parkinson, J.S. (2002) Collaborative signaling by 
mixed chemoreceptor teams in Escherichia coli, Proc Natl. Acad. Sci. USA, 99, 7060-
7065 
 
Ames, P., and J. S. Parkinson. (1988). Transmembrane signaling by bacterial 
chemoreceptors: E. coli transducers with locked signal output, Cell, 55, 817–826. 
 
Andersen JB, Sternberg C, Poulsen LK, Bjorn SP, Givskov M, Molin S. (1998) New 
unstable variants of green fluorescent protein for studies of transient gene expression in 
bacteria, .Appl Environ Microbiol. 64, 2240-2246. 
 
Angrand, I., Serrano, L. & Lacroix, E. (2001) Computer-assisted re-design of spectrin 
SH3 residue clusters, Biomol Eng., 18,125-134. 
 
Appleman, J. A., and V. Stewart. (2003). Mutational analysis of a conserved signal-
transducing element: the HAMP linker of the Escherichia coli nitratesensor NarX. J. 
Bacteriol. 185, 89–97. 
 
Aravind, L., Ponting, C.P. (1999) The cytoplasmic helical linker domain of receptor 
histidine kinase and methyl-accepting proteins is common to many prokaryotic signalling 
proteins.,FEMS Microbiol. Lett , 176, 111-116. 
 
Armitage JP. (1999) Bacterial tactic responses, Adv Microb Physiol., 41, 229-289. 
 
Artsimovitch, I., Svetlov, V, Anthony, L., Burgess, R.R., Landick, R. (2000) RNA 
Polymerases from Bacillus subtilis and Escherichia coli differ in recognition of 
regulatory signals in vitro, J. Bacteriol., 182, 6027-6035. 
 
Baumgartner, J.W. et al (1994) Transmembrane signalling by a hybrid protein: 
Communication from the domain of chemoreceptor Trg that recognises sugar-binding 
proteins to the kinase/phosphatase domain of Osmosensor EnvZ, J. Bacteriol., 176, 1157-
1164. 
 
 
References 103
Becskei, A., Seraphin, B., Serrano, L. (2001) Positive feedback in eukaryotic gene 
networks: cell differentiation by graded to binary response conversion, EMBO J., 20, 
2528-2535. 
 
Becskei, A., Serrano, L. (2000) Engineering stability in gene networks by autoregulation, 
Nature, 405, 590-593. 
 
Bergquist PL, Truman P. (1978) Degradation of missense mutant beta-galactosidase 
proteins in Escherichia coli K-12, Mol Gen Genet., 164, 105-108. 
 
Biemann HP, Koshland DE Jr. (1994) Aspartate receptors of Escherichia coli and 
Salmonella typhimurium bind ligand with negative and half-of-the-sites cooperativity., 
Biochem., 33, 629-634. 
 
Bjorkman, A. M.,Dunten, P., Sandgren, M. O.,Dwarakanath, V. N Mowbray, S. L. (2001) 
Mutations that affect ligand binding to the Escherichia coli aspartate receptor: 
implications for transmembrane signaling, J. Biol. Chem., 276, 2808-2815. 
 
Cai, S.J., Inouye, M. (2002) EnvZ-OmpR interaction and osmoregulation in Escherichia 
coli, J. Biol. Chem., 277, 24155-24161. 
 
Cai, S.J., Inouye, M. (2003) Spontaneous subunit exchange and biochemical evidence for 
trans-autophosphorylation in a dimer of Escherichia coli histidine kinase (EnvZ), J. Mol. 
Biol., 329, 495-503. 
 
Cai, S.J., Khorchid, A., Ikura, M., Inouye,.M. (2003) Probing Catalytically Essential 
Domain orientatiom in Histidine Kinase EnvZ by Targeted Disulfide crosslinking, J. Mol. 
Biol., 328, 409-418. 
 
Calvo, J.M., Matthews, R.G. (1994) The leucine responsive regulatory protein (Lrp), a 
global regulator of metabolism in Escherichia coli, Microbiol. Rev., 58, 466-490. 
 
Case CC, Bukau B, Granett S, Villarejo MR, Boos W (1986) Contrasting mechanisms of 
envZ control of mal and pho regulon genes in Escherichia coli, J Bacteriol., 166, 706-
712. 
 
Chen, S., Rosner, M.H., Calvo, J.M. (2001) Leucine-regulated self-association of Leucine 
responsive regulatory protein (Lrp) from Escherichia coli, J. Mol. Biol., 312, 625-635. 
 
Chung CT, Niemela SL, Miller RH. (1989) One-step preparation of competent 
Escherichia coli: transformation and storage of bacterial cells in the same solution, Proc 
Natl Acad Sci U S A, 86, 2172-2175. 
 
Clarke, S. Koshland D.E.Jr. (1979) Membrane receptors for aspartate and serine in 
bacterial chemotaxis, J. Biol. Chem., 254, 9695-9702. 
 
 
References 104
De Pina, K. et al (1995) Purification and characterization of the periplasmic nickel-
binding protein NikA of Escherichia coli K12, Eur. J. Biochem., 227, 857-865. 
 
Duke, T.A.J., Bray, D. (1999) Heightened sensitivity of a lattice of membrane receptors, 
Proc Natl. Acad. Sci. USA, 96, 10104-10108. 
 
Dutta, R., Inouye, M. (1996) Reverse phosphotransfer from OmpR to EnvZ in a kinase-
/phosphatase+ mutant of EnvZ (EnvZ.N347D), a bifunctional signal transducer of 
Escherichia coli, J. Biol. Chem., 271, 1424-1429. 
 
Ferrario, M. et al (1995) The Leucine-responsive regulatory protein of Escherichia coli 
negatively regulates transcription of ompC and micF and positively regulates translation 
of ompF, J. Bacteriol., 177, 103-113. 
 
Gardner, T.S., Cantor, C.R., Collins, J.J. (2000) Construction of a genetic toggle switch 
in Escherichia coli, Nature,  403, 339-342. 
 
Gestwicki, J.E., Kiassling, L.L. (2002) Inter-receptor communication through arrays of 
bacterial chemoreceptors, Nature, 415, 81-84. 
 
Goux W.J., Strong A.A., Schneider B.L., Lee W.N., Reitzer L.J. (1995) Utilization of 
aspartate as a nitrogen source in Escherichia coli. Analysis of nitrogen flow and 
characterization of the products of aspartate catabolism, J Biol Chem., 270, 638-646. 
 
Guerois, R., Nielsen, J.E. & Serrano, L. (2002) Predicting changes in the stability of 
proteins and protein complexes: a study of more than 1000 mutations, J Mol Biol, 320, 
369-387. 
 
Guerois, R. & Serrano, L. (2000) The SH3-fold family: experimental evidence and 
prediction of variations in the folding pathways, J Mol Biol, 304, 967-982. 
 
Guzman, L.M., Belin, D., Carson, M.J., Beckwith, J. (1995) Tight regulation, modulation 
and high-level expression by vectors containing the arabinose PBAD promoter, J. 
Bacteriol., 177, 4121-4130. 
 
Head, C.G., Tardy, A., Kenney, L.J. (1998) Relative binding of OmpR and OmpR-
phosphate at the ompF and ompC regulatory sites, J. Mol. Biol., 281, 857-870. 
 
Hsing,W.,. Russo, F.D,. Bernd, K.K.,. Silhavy T.J (1998) Mutations That Alter the 
Kinase and Phosphatase Activities of the Two-Component Sensor EnvZ, J. Bacteriol., 
180, 4538-4546. 
 
Huang L, Tsui P, Freundlich M. (1992) Positive and negative control of ompB 
transcription in Escherichia coli by cyclic AMP and the cyclic AMP receptor protein, J 
Bacteriol., 174, 664-670. 
 
 
References 105
Inoue, H., Nojima H., Okayama, H. (1990) High efficiency transformation of Escherichia 
coli with plasmids, Gene, 96, 23-28. 
 
Itou, H., Tanaka, I. (2001) The OmpR-Family of proteins: Insight into the tertiary 
structure and functions of Two-component regulator proteins, J. Biochem., 129, 343-350. 
Tomomori, C., et al (1999) Solution structure of the homodimeric core domain of 
Escherichia coli histidine kinase EnvZ, Nature Struct. Biol., 6, 729-734. 
 
Jin, T., Inouye, M. (1993) Ligand binding to the receptor domain regulates the ratio of 
kinase to phosphatase activities of the signalling domain of the Hybrid Escherichia coli 
transmembrane receptor, Taz1, J. Mol. Biol., 232, 484-492. 
 
Karlin S, Blaisdell BE, Bucher P. (1992) Quantile distributions of amino acid usage in 
protein classes, Protein Eng., 5, 729-738. 
 
Kay, W.W. (1971) Two aspartate transport systems in E.coli, J. Biol. Chem., 246, 7373-
7382. 
 
Khan, S., Trentham, D. R. (2004) Biphasic excitation by leucine in Escherichia coli 
chemotaxis, J. Bacteriol, 186, 588-592. 
 
Kim, K.K., Yokota, H., Kim S.H. (1999) Four helical-bundle structure of the cytoplasmic 
domain of a serine chemotaxis receptor, Nature, 400, 787-792. 
 
Krasilnikov, A.S., Podtelezhnikov, A., Vologodskii, A., Mirkin, S.M. (1999) Large-scale 
effects of transcriptional DNA supercoiling in vivo, J. Mol. Biol., 292, 1149-1160 
 
Lan, C.Y, Igo, M.M. (1998) Differential Expression of the OmpF and OmpC Porin 
Proteins in Escherichia coli K-12 depends upon the level of active OmpR, J. Bacteriol., 
180, 171-174. 
 
Lerner CG, Inouye M. (1990) Low copy number plasmids for regulated low-level 
expression of cloned genes in Escherichia coli with blue/white insert screening 
capability, Nucleic Acids Res., 18, 4631. 
 
Li, M., McClure, W.R., Susskind, M.M. (1997) Changing the mechanism of 
transcriptional activation by λ repressor, Proc. Natl. Acad. Sci. USA, 94, 3691-3696. 
 
Liu, X., Matsumara, P. (1994) The FlhD/FlhC complex, a transcriptional activator of the 
Escherichia coli flagellar class II operons, J. Bacteriol., 176, 7345-7351. 
 
Liu, Y., Levit, M., Lurz, R., Surrette, M.G., Stock, J.B. (1997) Receptor mediated protein 
kinase activation and the mechanism of transmembrane signaling in bacterial chemotaxis, 
EMBO J., 16, 7231-7240. 
 
 
References 106
Lutz, R., Bujard, H. (1997) Independent and tight regulation of transcriptional units in 
Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements, Nucleic 
Acid Research, 25, 1203-1210. 
 
Lybarger, S.R., Maddock, J.R. (2000) Differences in the polar clustering of the high- and 
low-abundance chemoreceptors of Escherichia coli, Proc Natl. Acad. Sci. USA, 97, 8057-
8062. 
 
Maddock, R.J., Shapiro, L. (1993) Polar location of the chemoreceptor complex in the  
Escherichia coli cell, Science, 259, 1717-1723. 
 
Manson, M.D., Blank, V., Brade, G., Higgins, C.F. (1986) Peptide chemotaxis in E.coli 
involves the Tap signal transducer and the dipeptide permease, Nature, 321, 253-256. 
 
Manson, M.D., Boos, W. (1985) Dependence of Maltose Transport and Chemotaxis on 
the amount of Maltose-Binding Protein, J. Biol. Chem., 260, 9727-9733 
 
Mao, H., Cremer, P.S., Manson, M.D. (2003) A sensitive, versatile microfluidic assay for 
bacterial chemotaxis, Proc Natl. Acad. Sci. USA, 100, 5449-5454 
 
Martinez-Flores, I., Cano, R., Bustamante, V.H., Calva, E., Puente, J.L. (1999) The ompB 
operon partially determines differential expression of OmpC in Salmonella typhi and 
Escherichia coli, J. Bacteriol., 181, 556-562. 
 
Mello, B. A. Tu, Y. (2003) Quantitative modeling of sensitivity in bacterial chemotaxis: 
the role of coupling among different chemoreceptor species, Proc Natl Acad Sci USA, 
100, 8223-8228. 
 
Mesibov, R., Adler, J. (1972) Chemotaxis towards amino acids in Escherichia coli, J. 
Bacteriol., 112, 315-326. 
 
Mizuno, T. (1998) His-Asp Phosphotransfer signal transduction, J. Biochem., 123, 555-
563. 
 
Mizuno, T., Chou, M.Y., Inouye, M. (1983) DNA sequence of the promoter region of the 
ompC gene and the amino acid sequence of the signal peptide of pro-OmpC protein of 
Escherichia coli, FEBS Letters, 151, 159-164. 
 
Mizuno, T., Mizushima, S. (1986) Characterization by deletion and localized 
mutagenesis in vitro of the promoter region of the Escherichia coli ompC gene and 
importance of the upstream DNA domain in positive regulation by the OmpR protein, J. 
Bacteriol., 168, 86-95. 
 
Mizuno, T., Mizushima (1987) Isolation and characterisation of deletion mutants of 
ompR and envZ, regulatory genes for expression of the outer membrane proteins OmpC 
and OmpF in Escherichia coli, J. Biochem., 101, 387-396. 
 
References 107
Moe GR, Bollag GE, Koshland DE Jr. (1989) Transmembrane signaling by a chimera of 
the Escherichia coli aspartate receptor and the human insulin receptor, Proc Natl Acad 
Sci U S A., 86, 5683-5687. 
 
Mowbray, S.L., Sandgren, M.O.J. (1998) Chemotaxis Receptors: A Progress Report on 
Structure and Function, J. Struct. Biol., 124, 257-275. 
 
Neidhardt, F.C. et al Escherichia coli and Salmonella cellular and molecular biology,., 
2nd Ed., (ASM Press, Washington). 
 
Nowlin, D.M., Nettleton, D.O., Ordal, G.W., Hazelbauer, G.L. (1985) Chemotactic 
transducer proteins of Escherichia coli exhibit homology with methyl-accepting proteins 
from distantly related bacteria, J. Bacteriol., 163, 262-266. 
 
Orth, P., Schnappinger, D., Hillen, W., Saenger, W., Hinrichs, W. (2000) Structural basis 
of gene regulation by the tetracycline inducible Tet repressor-operator system, Nature 
Struct. Biol., 7, 215-219. 
 
Ottemann, K.M., Xiao, W., Shin, Y.K, Koshland D.E. Jr (1999) A piston model for 
transmembrane signalling of the aspartate receptor, Science, 285, 1751-1754. 
 
Parkinson, J.S., Houts, S.E. (1982) Isolation and behaviour of Escherichia coli deletion 
mutants lacking chemotaxis functions, J. Bacteriol., 151, 106-113. 
 
Parkinson, J.S., Kofoid, E.C. (1992) Communication modules in bacterial signalling 
proteins, Annu. Rev. Genet., 26, 71-112. 
 
Perraud, A.L, Weiss, V., Gross, R. (1999) Signalling pathways in two-component 
phosphorelay systems, Trends Microbiol., 7, 115-120. 
 
Pruss, B.M. et al (2003) FlhD/FlhC is a regulator of anaerobic respiration and the Etner-
Doudoroff Pathway through induction of the methyl-accepting chemotaxis protein Aer, J. 
Bacteriol., 185, 534-543. 
 
Rampersaud, A., Harlocker, S.L., Inouye, M. (1994) The OmpR protein of Escherichia 
coli binds to sites in the ompF promoter region in a hierarchical manner determined by its 
degree of phosphorylation, J. Biol. Chem., 269, 12559-12566. 
 
Reader, R.W., Tso, W.W., Springer, M.S., Goy, M.F., Adler, J. (1979) Pleiotropic 
aspartate taxis andd serine taxis mutants of Escherichia coli, J. Gen. Microbiol., 111, 
363-374. 
 
Scott, W.G. et al (1993) Refined structures of the Ligand-binding domain of the aspartate 
receptor form Salmonella typhimurium, J. Mol. Biol., 232, 555-573. 
 
 
References 108
Sizemore, C, Wissmann, A., Gulland, U., Hillen, W (1990) Quantitative analysis of Tn10 
Tet repressor binding to a complete set of tet operator mutants, Nucleic Acids Research, 
18, 2875-2880. 
 
Sourjik, V., Berg, H.C. (2002) Receptor sensitivity in bacterial chemotaxis, Proc Natl. 
Acad. Sci. USA, 99, 123-127. 
 
Sourjik, V., Berg, H.C. (2004) Functional interactions between receptors in bacterial 
chemotaxis, Nature, 428, 437-441. 
 
Stock, J., Levit, M. (2000) Signal transduction: Hair brains in bacterial chemotaxis, Cur. 
Biol., 10, R11-14. 
 
Tatsuno, I., Kawagishi, I. Homma, M., Imae, Y. (1994) Transmembrane signalling by the 
chimeric chemosensory receptors of Escherichia coli Tsr and Tar with heterologous 
membrane-spanning regions, Mol. Microbiol., 14, 755-762. 
 
Tso, W.W., Adler, J. (1974) Negative chemotaxis in Escherichia coli, J. Bacteriol., 118, 
560-576. 
 
Umemura, T., Matsumoto, Y., Ohnishi, K., Homma, M., Kawagishi,. I. (2002) Sensing of 
cytoplasmic pH by bacterial chemoreceptors involves the linker region that connects the 
membrane-spanning and the signal-modulating helices, J. Biol. Chem., 277, 1593-1598. 
 
Utsumi, R. et al (1989) Activation of Bacterial porin gene expression by a chimeric 
signal transducer in response to aspartate, Science, 245, 1246-1249 
 
Vo, N.V., Hsu, L.M., Kane, C.M., Chamberlin, M.J. (2003) In vitro studies of transcript 
initiation by Escherichia coli RNA polymerase 3. Influences of individual DNA elements 
witin the promoter recognition region on abortive initiation and promoter escape, 
Biochem., 42, 3798-3811. 
 
Wadhams GH, Warren AV, Martin AC, Armitage JP. (2003) Targeting of two signal 
transduction pathways to different regions of the bacterial cell, Mol Microbiol. 50, 763-
770. 
 
Ward, S.M., Delgado, A., Gunsalus, R.P., Manson, M.D. (2002) A NarX-Tar chimera 
mediates repellent chemotaxis to nitrate and nitrite, Mol. Microbiol., 44, 709-719. 
 
Weerasuriya, S., Schneider, B.M., Manson, M.D. (1998) Chimeric Chemoreceptors in 
Escherichia coli: Signalling properties of Tar-Tap and Tap-Tar Hybrids, J. Bacteriol., 
180, 914-920. 
 
Weis, R.M., Hirai, T., Chalah, A., Kessel, M., Peters, J.P,, Subramaniam, S. (2003) 
Electron microscopic analysis of membrane assemblies formed by the bacterial 
chemotaxis receptor Tsr, J. Bacteriol., 185, 3636-3643. 
 
References 109
 
Wissman, A., Meier, I., Hillen, W. (1988) Saturation mutagenesis of the Tn10-encoded 
tet Operator O1, J. Mol. Biol., 202, 397-406. 
 
Wu HY, Shyy SH, Wang JC, Liu LF(1988) Transcription generates positively and 
negatively supercoiled domains in the template Cell. 53, 433-440. 
 
Wu HY, Tan J, Fang M. (1995) Long-range interaction between two promoters: 
activation of the leu-500 promoter by a distant upstream promoter, Cell, 82,445-451. 
 
Wuichet, K., Zhulin, I.B. (2003) Molecular evolution of sensory domains in 
cyanobacterial chemoreceptors, Trends in Microbiol., 11, 200-203. 
 
Yang, Y. Park, H., Inouye, M. (1993) Ligand binding induces an asymmetrical 
transmembrane signal through a receptor dimer, J. Mol. Biol., 232, 493-498. 
 
Zhu, Y., Inouye, M. (2003) Analysis of the role of the EnvZ linker region in signal 
transduction using a chimeric Tar/EnvZ receptor protein, Tez1, J. Biol. Chem., 278, 
22812-22819. 
 
